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Mood disorders and antidepressant treatments 
 
Depression and amine neurotransmitters 
 
 Mood disorders are among the most prevalent forms of mental illness. These are 
afflictions whereby the prevailing emotional mood is distorted or inappropriate to the 
circumstances, with a lifetime incidence of 10–25% in women and 5–12% in men 
(Blazer, 2000). Such pathologies are recurrent, life threatening due to the risk of suicide, 
and a major cause of morbidity worldwide. The most severe of these afflictions are major 
depression and manic depression; the latter also called “bipolar disorder” because such 
patients experience alternating episodes of depression and euphoria (Miklowitz & 
Johnson, 2006). 
Depression has been described for several millennia, nevertheless, a distinction 
between a disturbance of cognitive faculties (a thought disorder) and a disturbance of 
emotions (a mood disorder), was recently introduced during early development of 
modern classification of mental illnesses in the 20th century. The term melancholia, 
which means “black bile” in greek, was first used by Hippocrates around 400 B.C. to 
refer to an alteration of mood, which was thought to depend on the balance of four 
humors, blood, phlegm, yellow and black bile. An excess of black bile was believed to 
cause depression (see Kandel et al., 2000). Most symptoms of this pathology were 
recognized in ancient times, as were the contributions of innate predispositions and 
external factors in causing the illness. Clinically, depression is defined by a set of 
standard criteria which include: depressed mood, low self esteem, feelings of 
hopelessness, worthlessness and guilt, decreased ability to concentrate and think, altered 
appetite, insomnia or hypersomnia, low energy, increased agitation, decreased interest in 
pleasurable stimuli, e.g., sex, food, social interactions, and recurrent thoughts of death 
and suicide. A diagnosis of depression is made when a certain number of the above 
symptoms are reported for longer than a 2 week period of time, and when symptoms 
disrupt normal social and occupational functioning (reviewed in Nestler et al., 2002).  
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 There are four effective treatments for depression and bipolar disorders: 
electroconvulsive therapy (ECT), antidepressant drugs, lithium, and anticonvulsants. Of 
all the treatments, ECT has been used for the longest period of time, over 50 years. 
Although the therapeutic mechanism of ECT is not fully understood, it is thought to be 
related to alterations in the sensitivity of aminergic receptors (Nestler, 1998). Amine 
transmitters regulate many brain functions and are also active in the peripheral nervous 
system. Because biogenic amines are implicated in a wide range of behaviors, ranging 
from central homeostatic functions to cognitive phenomena such as attention, it is not 
surprising that defects in biogenic amines function are implicated in most psychiatric 
disorders. There are five well-established amine neurotransmitters, the three 
catecholamines: dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), 




Figure 1. Amine neurotransmitters. The catecholamines, so named because they all share the catechol 
moiety (i.e., a hydroxylated benzene ring), make up a distinctive subgroup within the biogenic amines. 
Serotonin and histamine contain an indole ring and an imidazole ring, respectively. Insert, space-filling 
model for norepinephrine. Taken from Purves et al., 2004.  
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 All catecholamines are derived from a common precursor, the amino acid 
tyrosine. Dopamine is synthesized in the brain stem and hypothalamus. Dopaminergic 
neurons in the substantia nigra and ventral tegmental area provide a major ascending 
pathway that terminates in the striatum, the prefrontal and temporal cortex as well as the 
limbic system. Hypothalamic dopaminergic neurons instead, provide descending 
pathways to autonomic areas of the brain stem and the spinal cord (see Kandel et al., 
2000). Dopamine is believed to be involved in motivation, reward and reinforcement, and 
plays also a poorly understood role in some sympathetic ganglia (Feldman et al., 1997).  
Norepinephrine is used as a neurotransmitter in the locus coeruleus, a brainstem 
nucleus that projects diffusely to a variety of forebrain targets and influences sleep and 
wakefulness, attention and feeding behavior (reviewed in Berridge & Waterhouse, 2003). 
The most prominent noradrenergic neurons are sympathetic ganglion cells, which employ 
norepinephrine as the major peripheral transmitter. Epinephrine-containing neurons in the 
central nervous system, instead, are primarily in the lateral tegmental system and in the 
medulla and project to the hypothalamus and thalamus (Feldman et al., 1997). Serotonin 
(5-HT), in contrast, is synthesized from the amino acid tryptophan and is found in groups 
of neurons in the raphe regions of the pons and upper brain stem, which have widespread 
projections to the forebrain with an important role in sleep, wakefulness and behavioral 
arousal (Abrams et al., 2004).  
 
Antidepressant drugs (ADs). Historical perspective. 
 
The functionality of amine synapses is critically important in 
psychopharmacology, with drugs affecting the synthesis, receptor binding, or catabolism 
of these neurotransmitters being among the most important agents of the modern 
pharmacology. Following their synthesis in the cytoplasm of presynaptic terminals, all 
the amine transmitters are packaged in synaptic vesicles and released into the synaptic 
cleft by means of exocytosis when the neurons fires an action potential. The 
neurotransmitter then interacts with pre- and post-synaptic receptors, and such activity is 
limited by active reuptake of the released molecule into presynaptic terminals as well as 
into glial cells (Feldman et al., 1997) (Figure 2). Inside the presynaptic terminals the 
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transmitters are packaged again into vesicles or catabolized primarily by the 







Figure 2. Serotonin synapse. Schematic diagram illustrating the synthesis, metabolism, neurotransmitter 
release and pre-synaptic reuptake. Pre and postsynaptic receptors and sites of action of some antidepressant 
drugs are shown. Note that fluoxetine selectively inhibits the presynaptic reuptake of 5-HT, which 
enhances the postsynaptic serotonergic transmission. Taken from Feldman et al., 1997. 
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Drugs effective in treating depression act primarily on the serotonergic and 
noradrenergic systems of the brain (reviewed in Wong et al., 1995). The first drug used to 
ameliorate mood disorders, in particular schizophrenia, was reserpine. It was developed 
in the 1950s and initially used as treatment for hypertension because it blocks the 
noradrenergic transmission causing a reduction in the ability of the sympathetic division 
of the visceral motor system to cause constriction of blood vessels (Purves et al., 2004). 
Soon after, it was clear that a major side effect in hypertensive patients treated with 
reserpine was depression. It was then found that reserpine decreases serotonin and 
noradrenaline levels by inhibiting the uptake of neurotransmitters into synaptic vesicles, 
in the presynaptic terminal (see Figure 2), thereby keeping the transmitter into the 
cytoplasm where it undergoes degradation by the mitochondrial enzymes monoamine 
oxidase (Pletscher et al., 1956). This finding was of importance because it suggested the 
possibility that alterations in monoaminergic transmission might be involved in disorders 
of mood.     
 The monoamine hypothesis of depression, as first described in the 1960s, stated 
that depression was caused by a deficiency in the serotonergic and noradrenergic systems 
at functionally important receptor sites in the brain (Bunney et al., 1965; Schildkraut, 
1965; Coppen, 1967). Indeed, the first drugs identified as antidepressants were 
discovered by chance when medications developed for other illnesses were found to 
elevate mood of psychiatric patients. Particularly, isoniazid, a drug initially used as 
treatment of tuberculosis, was found to ameliorate mood of patients receiving it. Later 
studies performed in depressed patients, who did not have tuberculosis, demonstrated an 
antidepressant effect of the drug. Isoniazid increases the concentration of serotonin and 
noradrenaline by interfering with the degradation of these neurotransmitters by the 
enzyme MAO, thus increasing its total content in the axonic terminals of neurons (see 
Figure 2). Further support to this notion came with the discovery that imipramine, an 
experimental antihistamine with a tricyclic structure, induced antidepressant effects. 
Imipramine blocks the reuptake of both serotonin and noradrenaline to the presynaptic 
nerve endings, thereby prolonging the action of these transmitters in the synapse 
(reviewed in Castren, 2005). These findings revolutionized the recognition and treatment 
of mood disorders shedding light into some of the molecular mechanisms involved in 
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depression. Because it became clear that both isoniazid and imipramine increase the 
extracellular levels of two important neurotransmitters in the brain: serotonin and 
noradrenaline; an increase in the total concentration of these neurotransmitters after 
treatment with these two drugs was the starting point for the proposal of the monoamine 
hypothesis of depression.   
 
Neuronal circuitries affected in depression 
 
 Abnormalities in many brain areas are thought to mediate the diverse symptoms 
of depression. This notion is supported by human brain imaging studies which have 
demonstrated changes in blood flow in several brain regions, including areas of prefrontal 
and cingulate cortex, hippocampus, striatum, amygdala and thalamus. Similarly, 
anatomic studies of brains of depressed patients obtained at autopsy report abnormalities 
in many of these same brain regions (for review see Nestler et al., 2002). Knowledge of 
the function of such brain areas under normal conditions suggest the aspects of 
depression to which they may contribute. Neocortex and hippocampus may mediate 
cognitive aspects of depression, such as memory impairments and feeling of 
worthlessness, hopelessness, guilt and recurrent thoughts of suicide. The ventral striatum 
or nucleus accumbens, and the amygdale, are important in emotional memory and could 
as a result mediate the decreased drive and reward for pleasurable activities, anxiety, and 
reduced motivation that predominate in many patients (reviewed in Nestler et al., 2006).  
 A prominent mechanism by which the brain reacts to acute and chronic stress is 
the activation of the hypothalamic-pituitary-adrenal (HPA) axis. Under such conditions, 
neurons in the paraventricular nucleus (PVN) of the hypothalamus secrete corticotrophin 
releasing factor (CRF), which stimulates the synthesis and release of adrenocorticotropin 
(ACTH) from the pituitary gland. ACTH then stimulates the synthesis and release of 
glucocorticoids (cortisol in humans, corticosterone in rodents) from the adrenal cortex. 
Glucocorticoids exert profound effects on general metabolism and dramatically affects 
behavior via direct actions on numerous brain regions (reviewed by Nestler et al., 2002). 
The activity of the HPA axis is controlled by different brain pathways, including an 
inhibitory action exerted by the hippocampus and an excitatory action mediated by the 
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amygdala. Levels of glucocorticoids that are seen under normal physiological conditions 
seem to enhance hippocampal inhibition of HPA activity. They may also enhance general 
hippocampal functions and promote certain cognitive abilities. However, sustained 
elevations of glucocorticoids seen under conditions of stress or depression may damage 
hippocampal neurons particularly CA3 pyramidal cells (Sapolsky, 2000). Stress and the 
resulting increase in cortisol also reduce neurogenesis in the adult hippocampal dentate 
gyrus (Fuchs & Gould, 2000), which in turn reduces the inhibitory hippocampal action on 
the HPA axis; further increasing circulating glucocorticoid levels and subsequent 
hippocampal damage. Such positive feedback process with pathological consequences 
has been implicated in the onset of depression. Abnormal, excessive activation of the 
HPA axis is observed in approximately 50% of depressed patients and these 
abnormalities are corrected by antidepressant treatment (Arborelius et al., 1999; 
Holsboer, 2001).  
 
Hypothesis for the etiology of depression 
 
 The pathologic effects of stress on hippocampus have contributed to a hypothesis 
for depression that proposes a role for neurotrophic factors in the etiology of this 
pathology and its treatment (Duman et al., 1997). Neurotrophic factors were first 
characterized by regulating neuronal growth and differentiation during development, but 
it has become clear that they are also potent regulators of plasticity and survival of adult 
neurons. The neurotrophic hypothesis of depression states that a deficiency in 
neurotrophic support may contribute to hippocampal pathology during the development 
of the illness, and that reversal of this deficiency induced by antidepressant treatments 
ameliorate the symptoms. Work in this hypothesis has focused on the brain derived 
neurotrophic factor (BDNF) (Reviewed in D’Sa & Duman, 2002), one of the most 
prevalent neurotrophins in the adult brain. Acute and chronic stress decrease levels of 
BDNF expression in the dentate gyrus and pyramidal cell layer of hippocampus in 
rodents. This reduction appears to be mediated partly via stress-induced glucocorticoids 
and partly by stress-induced decrease in serotonergic transmission (Smith et al., 1995). 
Conversely, chronic administration of virtually all classes of antidepressant treatments 
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increases BDNF expression in these regions (Nibuya et al., 1995), and prevent the stress-
induced decrease in the neurotrophin levels. These findings raise the possibility that 
antidepressant induced upregulation of BDNF could repair some stress-induced damage 
to the hippocampus and protect vulnerable neurons from further damage. Furthermore, an 
enhancement of long-term potentiation and other forms of synaptic plasticity induced by 
BDNF in the hippocampus has been reported (Korte et al., 1996; Kang et al., 1997), 
which suggests that BDNF induced by antidepressants may promote hippocampal 
function. Importantly, these findings could also explain why the clinical antidepressant 
response show a time delay of several weeks: it would require sufficient time for levels of 
BDNF to gradually raise and exert its neurotrophic effects.   
 The neurotrophic hypothesis predicts that agents that promote BDNF expression 
and signaling might be clinically effective antidepressants, so different approaches 
focusing on understanding BDNF gene expression following antidepressant treatment 
have been developed. There is evidence for the transcription factor cAMP-response-
element binding protein (CREB) regulating BDNF expression. For instance, BDNF 
expression is induced in vitro and in vivo by CREB (Tao et al., 1998; Conti et al., 2002) 
and all major classes of antidepressants increase levels of CREB expression and function 
in several brain regions including the hippocampus (Nibuya et al., 1996; Thome et al., 
2000). An increase in CREB activity by microinjections of a viral vector encoding CREB 
into the hippocampal dentate gyrus exerts antidepressant-like effects, as evidenced in the 
forced swim test and learned helplessness test (Chen et al., 2001). In contrast, levels of 
CREB are reduced in the temporal cortex of depressed patients (Dowlatshahi et al., 
1998). While these effects could be mediated by numerous target genes under control of 
CREB, it does illustrate novel strategies by which influencing hippocampal function in 
the context of depression, and makes likely a role for BDNF on it. Indeed, it has been 
demonstrated that single bilateral infusions of BDNF into the dentate gyrus of 
hippocampus or the overexpression of its primary receptor TrkB produce an 
antidepressant effect in behavioral models of depression (Shirayama et al., 2002; 
Koponen et al., 2005).  
 Importantly, experimental evidence arguing against the possibility that an 
impairment of BDNF-TrkB signaling may underlie the pathophysiology of depression 
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has been recently found. Mice lacking the tyrosine kinase receptor TrkB in the forebrain 
and transgenic mice overexpressing the dominant-negative T1 form of TrkB, for instance, 
show no depressive behavior (Zorner et al., 2003; Saarelainen et al., 2003). In contrast, in 
both BDNF knockouts and TrkB.T1 transgenic mice antidepressant treatment no longer 
induces a reduction of immobility in behavioral models of depression (Saarelainen et al., 
2003), indicating that BDNF-TrkB signaling is necessary to mediate the behavioral 
response induced by antidepressants but may not be involved in the etiology of 
depression (reviewed in Martinowich et al., 2007).  
Most of the clinical studies have focused on the hippocampus as the site involved 
in the generation and treatment of depression (Reviewed by Campbell & Macqueen, 
2004). However, while the hippocampus is undoubtedly involved in the illness, it is 
unlikely that it accounts completely for these phenomena. The pathology in the 
hippocampus explains symptoms like alterations in learning and memory seen in 
depression but it does not represent the wide spectrum of symptoms. Brain imaging and 
autopsy studies have provided evidence for abnormalities in several brain areas of 
depressed individuals well beyond the hippocampus. The role of subcortical structures 
like the hypothalamus and amygdala in the regulation of motivation, sleep, appetite, 
energy levels, circadian rhythms, and responses to pleasurable stimuli, prominently 
affected in depressed patients, has also been recognized (reviewed in Nestler et al., 2002). 
Given the pervasive symptoms of depression, it is likely that the pathophysiology of this 
disorder and the mechanisms by which currently available treatments reverse symptoms, 
involve diverse neural circuits in numerous brain regions. 
Recent experimental findings support an alternative hypothesis for depression 
which proposes a role for neurogenesis in its etiology. Magnetic resonance imaging 
studies have shown a reduction of hippocampal volume in depressed patients, event that 
has been correlated to a reduction of the number of hippocampal neurons (Videbech & 
Ravnkilde, 2004; Campbell et al., 2004). In addition, all clinically effective 
antidepressant drugs increase neurogenesis in the adult hippocampus (Malberg et al., 
2000). Even though these findings indicate adult hippocampal neurogenesis as a 
candidate mechanism for the etiology of depression and as a substrate of antidepressant 
action, there is evidence arguing against it. For instance, at structural level it is highly 
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unlikely that changes in adult hippocampal neurogenesis account for the reduction of 
hippocampal volume observed in depressed patients. Stereological analysis of 
hippocampal volume in irradiated mice indeed, a strategy that impairs adult hippocampal 
neurogenesis, revealed no a significant reduction of volume in the hippocampus 
(Santarelli et al., 2003). In addition the fact that ablation of neurogenesis does not elicit a 
depression-like behavioral phenotype undermines a role for neurogenesis in the etiology 
of depression (Airan et al., 2007; Santarelli et al., 2003).     
In contrast to the neurotrophic or neurogenic view of depression recent 
observations support an alternative hypothesis for such neurological disorder, which 
suggests that an impaired activity-dependent neuronal signaling may underlie this 
pathology and that antidepressant drugs might exert a therapeutic effect by enhancing 
information processing in the affected neuronal networks through activity-dependent 
mechanisms of synaptic plasticity (reviewed by Castren, 2005). This alternative idea, 
known as the network hypothesis, predicts that depression arise from an impaired 
synaptic plasticity in the CNS rather than from an alteration in the balance of signaling 
molecules. Evidence supporting this notion comes from the finding that disruption of 
adult hippocampal neurogenesis impairs the antidepressant-like behavioral response 
induced by antidepressants drugs (Santarelli et al., 2003). According to this idea, 
antidepressants may promote mechanisms of neuronal plasticity through an initial effect 
on monoamine metabolism, leading to an improved processing of information in neuronal 
networks involved in mood regulation (reviewed by Castren, 2005). Interestingly, 
differentiation of newly generated neurons takes several weeks (van Praag et al., 2002) 
which is a time course that correlates with the delayed onset of the therapeutic effects 
induced by antidepressant drugs. These findings suggest a role for neuronal plasticity in 
the action of ADs. 
 
ADs and neuronal plasticity 
 
Despite years of study, the biological basis of depression and the precise 
mechanisms of antidepressant efficacy remains unclear. Early research on depression 
focused on changes in neurotransmitter concentrations and its receptors. The results of 
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these studies, however, were in disagreement with clinical observations of the therapeutic 
action of ADs. Although the effects of antidepressants on monoamine metabolism occur 
soon after administration, it typically takes several weeks of continued treatment for the 
clinical antidepressant response to appear (Nestler et al, 1998). Further research made 
clear that long-term antidepressant treatment produces adaptive changes in monoamine 
receptors and intracellular signal transduction pathways associated (Sulser et al., 1978), 
which centered the attention on the effects of long-term antidepressant treatments on 
neurotrophic factors and coupled receptors as well as on intracellular signaling molecules 
(Duman et al., 1997; Manji et al., 2001; Coyle & Duman, 2003).  
 
Increased BDNF expression induced by ADs 
 
Research on the therapeutic effects induced by chronic administration of 
antidepressants has been developed focusing on the regulation of key signaling pathways 
involved in cellular survival, neurogenesis and neuronal plasticity in the adult brain. The 
fact that chronic antidepressant treatment increases the expression of BDNF and its 
primary receptor TrkB, in the frontal cortex and hippocampus of adult rats, was early 
demonstrated by Nibuya et al. in 1995 using in situ hybridization and northern blot 
analysis. Because neurotrophins were known to promote growth and development of 
immature neurons as well as to enhance the survival and function in neural cells in the 
adult (for review see Lindvall et al, 1994), a possible role for BDNF in mediating the 
therapeutic effects induced by antidepressants was suggested. That neurogenesis in the 
adult rat hippocampus is increased by chronic antidepressant treatment was elegantly 
shown by Malberg et al. (2000). In this study, different types of ADs were systemically 
given to adult animals and the acute and chronic effects on hippocampal neurogenesis 
were assessed by immunohistochemistry using the thymidine analogue 
bromodeoxyuridine (BrdU) as a marker for dividing cells. The authors found an 
increased number of BrdU labelled cells in the dentate gyrus of the adult rat hippocampus 
after chronic antidepressant administration but not after acute treatment. Moreover, an 
enhanced proliferation of hippocampal cells and differentiation into mature neurons was 
shown by combining BrdU labelling with specific markers for neuronal and glial cells. 
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These findings not only suggested a common molecular event induced by different ADs 
but highlighted a mechanism that is consistent with the time course for the therapeutic 
actions of antidepressants. 
It has also been observed that adult neurogenesis and BDNF-induced TrkB 
signaling are critical molecular events in mediating the therapeutic effects of ADs. In a 
very elegant set of experiments Santarelli et al. (2003) showed that the antidepressant-
like behavioral response to ADs is blocked if hippocampal neurogenesis is disrupted 
through a restricted x-irradiation in the mouse brain. These data provided a correlation 
between behavioral responses induced by antidepressants and the induction of 
hippocampal neurogenesis and suggest that generation of neural cells in the adult 
hippocampus may be necessary for the therapeutic action induced by ADs. On the other 
hand, single bilateral infusion of BDNF into the dentate gyrus of hippocampus was 
shown to induce an antidepressant effect in two behavioral models of depression: the 
learn helplessness and forced swim test (Shirayama et al., 2002). Furthermore, the 
authors evaluated whether a decreased phosphorylation of the primary BDNF receptor 
TrkB, induced by co-administration of BDNF with a broad spectrum tyrosine kinase 
inhibitor (K252a) into the hippocampus, impaired the antidepressant-like behavioral 
response induced by the neurotrophin in the learn helplessness test. K252a cortical 
administration completely blocked the behavioral effects induced by cortical BDNF 
administration. Taken together, these data suggest a correlation between BDNF-TrkB 
signaling and adult hippocampal neurogenesis, which may account for the behavioral 
effects induced by antidepressants. Experimental evidence in support to this notion comes 
from the finding that cortical administration of exogenous BDNF in adult animals not 
only increases CREB phosphorylation, but enhances long-term potentiation (LTP) of 
neural transmission in the adult hippocampus (Ying et al., 2002). 
One important mechanism at the basis of the therapeutic action of ADs is the 
phosphorylation of the transcription factor cAMP-response element binding protein 
(CREB), which is known to promote BDNF expression. Direct evidence for the 
regulation of gene transcription via the cAMP-mediated second messenger pathway 
implicated in the actions induced by antidepressants was obtained in vivo using 
transgenic mice with a CRE-LacZ reporter gene construct (Thome et al., 2000). In these 
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mice, stimulation of the CRE site leads to an increase expression of the LacZ gene 
product, β-galactosidase, making it possible to evaluate the influence of antidepressant 
administration on CRE-mediated gene transcription. Levels of β-galactosidase assessed 
by fluorescence immunohistochemistry revealed an increased CRE-mediated gene 
transcription in limbic structures and cerebral cortex, induced by chronic treatment with 
three distinct classes of antidepressants. Furthermore, immunohistochemical analysis for 
p-CREB revealed that chronic antidepressant treatment increased phosphorylation of 
CREB, result that was consistent with the enhanced CRE-mediated gene expression. 
These findings, together with those of Nakagawa et al. (2002) in which the 
phosphorylation of CREB was shown to be required for hippocampal neurogenesis 
induced by the antidepressant rolipram, indicate a critical role for CREB phosphorylation 
in mediating the therapeutic effects of antidepressant drugs. 
 
ADs and synaptic plasticity 
 
Recent studies in animal models suggest that antidepressant treatments enhance 
synaptic connectivity in the brain. Particularly, an increased dendritic spine synapse 
formation in the adult rat hippocampus and frontal cortex was shown to be induced by 
chronic administration of the selective serotonin reuptake inhibitor (SSRI) fluoxetine 
(Hajszan et al., 2005). In depressed patients, brain imaging and neuropathological studies 
point toward a reduced neuronal activity and synaptic connectivity in the brain as 
evidenced by a decreased hippocampal and prefrontal cortex volume (reviewed by 
Castren, 2004) and antidepressant treatment seems to prevent or restore the structural and 
functional deficits observed in depression (Czeh et al., 2001).   
The role of ADs in the remodeling and strengthening of specific neural synapses 
in the adult brain has also been addressed in rodents. Sairanen et al. (2007) evaluated the 
effect of chronic antidepressant treatment on the expression of three plasticity associated 
marker proteins: the polysialylated form of the nerve cell adhesion molecule (PSA-
NCAM), the phosphorylated form of CREB (p-CREB) and the growth-associated protein 
43 (GAP-43). PSA-NCAM is a cell surface protein involved in the regulation of axon 
growth (Cremer et al., 1997) and has been associated with the differentiation of newly 
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generated neurons in the rodent hippocampus (Seki & Arai, 1993), cell migration 
(Yoshida et al., 1999), synaptogenesis (Dityatev et al., 2004) and long-term potentiation 
of neural transmission (Muller et al., 1996; Cremer et al., 1998), while the 
phosphorylated form of CREB is known to be a permissive factor for neuronal plasticity. 
The GAP-43 protein is critically involved in synaptogenesis, axonal sprouting and the 
regulation of the cytoskeletal organization in the nerve ending (Benowitz & Routtenberg, 
1997). Thus, Sairanen et al. (2007) assessed the expression of these proteins using 
immunohistochemistry to study mechanisms of synaptic plasticity induced by chronic 
treatment with the antidepressant imipramine on different areas in the forebrain of adult 
rats. Increased levels of PSA-NCAM, p-CREB and GAP-43 were found to be induced by 
chronic but not acute imipramine treatment in the hippocampus, medial prefrontal cortex 
and piriform cortex of adult animals, indicating an effect of antidepressants on the 
remodeling of neuronal networks. 
Recent experimental evidence also suggests that a disturbance of brain plasticity 
is involved in animal models of depression and that chronic antidepressant treatment may 
counteract these alterations. In a set of elegant experiments adult rats were exposed to 
chronic mild stress conditions for three weeks to examine later long-term synaptic 
plasticity in the hippocampal CA1 region by whole-cell patch clamp (Holderbach et al., 
2007). The authors found that chronic mild stress facilitated long-term depression (LTD) 
and had no effect on long-term potentiation (LTP), while chronic treatment of the SSRI 
fluvoxamine during the stress paradigm prevented the induction of LTD and increased 
the extent of LTP induction. Moreover, LTP was shown to be enhanced in non-stressed 
animals treated with fluvoxamine compared to stressed and non-stressed rats, which 
suggested an effect of antidepressants on synaptic plasticity of normal subjects. 
More recently, Normann et al. (2007) assessed this notion by using visual evoked 
potentials (VEPs) as a model to study cortical responses and its plasticity in the human 
visual system. Since repeated presentation of visual stimuli is known to produce a form 
of learning which subsequently improves the perception of these stimuli, the authors were 
able to assessed synaptic transmission in depressed patients and healthy individuals after 
chronic treatment with the SSRI sertraline. The neuronal correlates of perceptual learning 
in the visual system have been studied in awake mice (Frenkel et al., 2006), in which the 
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enhancement of evoked responses after repetitive presentation of visual stimuli is thought 
to reflect an increased long-term synaptic plasticity, as similarly suggested for the human 
visual system (Teyler et al., 2005). Normann et al. (2007) showed that chronic 
antidepressant administration in healthy human subjects increases the amplitude of early 
components (P1 and N1) of visual evoked potentials (VEPs) in response to repeated 
presentation of visual stimuli, whereas the polarity of such modulation was inverted in 
depressed patients. Taken together, these data suggest a role for neuronal plasticity in the 
action of ADs. How changes in plasticity are translated into the therapeutic effects 
induced by ADs is, however, currently unknown. 
 
Critical periods for experience-dependent plasticity 
 
The rich diversity of human personalities, abilities, and behavior is undoubtedly 
generated by the uniqueness of individual human brains. These fascinating 
neurobiological differences among human beings derive from both genetic and 
environmental influences. The first steps in the construction of neural circuitries, i.e., the 
establishment of distinct brain regions, the generation of neurons, the formation of major 
axon tracts, the guidance of growing axons to appropriate targets, and the initiation of 
synaptogenesis, rely largely on the tight interaction between genes and environment. 
Once the basic patterns of neural connections in the brain are established, however, 
patterns of neuronal activity (including those that are elicited by experience) modify the 
synaptic circuitry of the developing brain. Neuronal activity generated by interactions 
with the external world in postnatal life thus provides a mechanism by which the 
environment can influence brain structure and function.  
The neural mechanisms that result from genetic and environmental interactions 
and their developmental consequences are sufficient to create some remarkably 
sophisticated innate behaviors. For most animals, the behavioral repertoire, including 
foraging, fighting and mating strategies, largely relies on patterns of connectivity 
established by intrinsic developmental mechanisms. However, the nervous system clearly 
adapts to and is influenced by the particular circumstances of an individual’s 
environment. These environmental factors are especially influential in early life, during 
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temporal windows called “critical periods”. Psychologists and ethologists have long 
recognized this notion, that early postnatal life is a period of special sensitivity to 
environmental influences on animal’s behavior. It is thought to be a critical period during 
which a given behavior is especially susceptible to, an indeed requires, specific 
environmental influences to develop normally (Purves et al., 2004). Once this period 
ends, such behavior is largely unaffected by subsequent experience and the failure to be 
exposed to appropriate stimuli during the critical period causes alterations that are 
irreversible on late developmental stages.  
 
Avian song learning 
 
The existence of critical periods has been demonstrated in several species 
(reviewed by Berardi et al., 2000) which include, for instance, song in birds and language 
in humans. Particularly well characterized is the sensitive period for learning courtship 
songs by oscine songbirds such as canaries and finches (reviewed by Doupe & Kuhl, 
1999). In these species, the quality of early sensory exposure is the major determinant of 
subsequent perceptual and behavioral capabilities. The developmental periods for 
learning these and other behaviors are restricted during postnatal life, suggesting that the 
nervous system changes in some manner to become refractory to further experience. 
Thus, avian song learning illustrates the interactions between intrinsic and 
environmental factors in this developmental process. Many birds sing to attract mates, but 
oscine songbirds are special in that their courtship songs are dependent on auditory and 
vocal experience. The sensitive period for song learning comprises an initial stage of 
sensory acquisition, when the juvenile bird listens to and memorizes the song of a nearby 
adult male tutor (usually of its own species), and a subsequent stage of vocal learning, 
when the young bird matches its own song to the now memorized tutor model via 
auditory feedback. This sensory motor learning stage ends with the onset of sexual 
maturity, when songs become acoustically stable. Even constant exposure to other songs 
after sensory acquisition at the end of the sensitive period does not affect this memory: 
the songs heard during sensory acquisition, but not later, are those that the bird vocally 
mimics (Purves et al., 2004). 
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On the other hand, additional features of song learning indicate an intrinsic 
predisposition for this specialized form of vocal learning. First, juveniles often need to 
hear the tutor song only 10 or 20 times to then vocally mimic it many months later. 
Second, when presented with a variety of songs played from tape recordings that include 
their own and other species’ songs, juvenile birds preferentially copy the song of their 
own species, even with no external reinforcement (reviewed in Doupe & Kuhl, 1999). 
These observations show that juveniles are not really “naive,” but are innately biased to 
learn the songs of their own species over those of others. Therefore, intrinsic factors 
make the nervous system of oscine birds especially sensitive to songs that are species 
typical. It is likely that similar biases influence human language learning. 
 
Language in human beings 
 
In contrast to canaries and finches, human beings require large postnatal 
experience to produce and decode speech sounds that are the basis of language. The 
various forms of early language exposure, including the “baby talk” that parents and 
other adults often use to communicate with children as they begin to acquire language 
may actually serve to emphasize important perceptual distinctions that facilitate proper 
language production and comprehension (Purves et al., 2004).  Importantly, for this 
linguistic experience to be effective it must occur in early life. The requirement for 
perceiving and practicing language during a critical period is apparent in studies of 
language acquisition in congenitally deaf children. Whereas most babies begin producing 
speech like sounds at about 7 months (babbling), congenitally deaf infants show obvious 
deficits in their early vocalizations, and such individuals fail to develop language if not 
provided with an alternative form of symbolic expression. If, however, these deaf 
children are exposed to sign language at an early age, they begin to “babble” with their 
hands just as a hearing infant babbles audibly (Petitto & Marenhette, 1991). This suggests 
that, regardless of the modality, early experience shapes language behavior. 
Examples of pathological situations in which normal children were never exposed 
to a significant amount of language point toward the same notion. One well-documented 
case is that of a girl who was raised by deranged parents until the age of 13 under 
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conditions of almost total language deprivation. Despite intense subsequent training, she 
never learned more than a rudimentary level of communication (see Kandel et al., 2002). 
This and other examples of so-called “feral children” starkly define the importance of 
early experience for language development as well as other aspects of social 
communication and personality. In contrast to the devastating effects of deprivation on 
children, adults retain their ability to speak and comprehend language even after long 
periods without exposure to human communication. The normal acquisition of human 
speech is subject to a critical period: the process is sensitive to experience or deprivation 
during a restricted period early in life and is relatively refractory to similar experience or 
deprivations in adulthood. 
 
Critical period for visual system development 
 
Although critical periods for language and other distinctively human behaviors are 
in some ways the most compelling examples of this phenomenon, it is difficult to study 
the underlying changes in the human brain. A much clearer understanding of how 
changes in connectivity might contribute to critical periods has come from studies of the 
developing visual system in experimental animals with highly developed visual abilities, 
particularly cats and monkeys. In an extraordinarily influential series of experiments in 
the 1960s, David Hubel and Torsten Wiesel found that depriving animals of normal 
visual experience during a restricted period of early postnatal life irreversibly alters 
neuronal connections and functions in the visual cortex. These observations provided the 
first evidence that the brain translates the effects of early experience, i.e., patterns of 
neural activity, into more or less permanently altered wiring of neural circuitries. 
Electrophysiological recordings from the primary visual cortex of adult cats 
evidenced that the two eyes differentially activated cortical neurons and cells with similar 
preference for one eye were grouped together into ocular dominance columns (Hubel & 
Wiesel, 1963). It became clear that sensory inputs from the two eyes are first integrated 
in the primary visual cortex, where most afferents from the lateral geniculate nucleus of 
the thalamus terminate. In most mammals the afferent terminals form an alternating 
series of eye-specific domains in cortical layer IV called ocular dominance columns, 
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which are represented as stripes of cortical neurons that are driven only by stimulation of 
one eye or the other. All these units, together with orientation columns, are functionally 
organized into hypercolumns which process visual stimuli from discrete regions of the 
visual field. Thus, using electrophysiological recordings Hubel & Wiesel (1963) found 
that ocular dominance distribution across cortical layers of the visual cortex is roughly 








Figure 3.  Ocular dominance distribution of single cell recordings in the visual cortex of adult cats. Cells in 
group 1 and 7 are activated only by the contralateral or by the ipsilateral eye, respectively. Group 4 cells are 
driven by both eyes equally while 2/3 and 5/6 driven mainly by contra and ipsi eye, respectively. Taken 







The researchers then asked whether this normal distribution of ocular dominance 
could be altered by visual experience. Using single cell recordings, they observed that 
occluding one eye early in development (a treatment referred to as monocular 
deprivation) led to the reduction in the number of cortical cells responding to that eye, in 
parallel with a robust increment in the number of neurons activated by the open eye 
(Wiesel & Hubel, 1963; Hubel & Wiesel, 1970) (Figure 4A). In contrast, monocular 




Figure 4.  Effect of early closure of one eye on the ocular dominance distribution in the visual cortex. (A) 
Following closure of one eye from 1 week after birth until 2.5 months, no cells could be activated by the 
deprived contralateral eye. Some cells could not be activated by either eye (NR). (B) A much longer period 
of monocular deprivation in an adult cat had little effect on ocular dominance distribution, though the 
overall cortical activity was diminished. Taken from Purves et al., 2004.      
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Recordings from the retina and lateral geniculate layers related to the deprived eye 
indicated that these more peripheral stations in the visual pathway worked quite 
normally. Thus, the absence of cortical cells that responded to stimulation of the closed 
eye was not a result of retinal degeneration or a loss of retinal connections to the 
thalamus. Rather, the deprived eye had been functionally disconnected from the visual 
cortex. Consequently, such animals are behaviorally blind in the deprived eye.  
Because the same treatment is completely ineffective in the adult animal (Figure 
4B), this early temporal window characterized by enhanced plasticity in response to 
experience is a typical example of a critical period. The shift in the ocular dominance 
distribution in response to monocular deprivation has been reported to occur in all 
mammals tested (reviewed by Berardi et al., 2000), accompanied by other dramatic 
effects such as poor development of visual acuity for the deprived eye, a condition known 
as amblyopia (reviewed in Odom, 1983) which is a permanent pathology in the adult. 
Even if the formerly deprived eye is subsequently left open indefinitely, little or no 
recovery of visual acuity occurs. Similar experiments in the monkey have shown that the 
same phenomenon occurs in primates, although the critical period is longer than in cats, 
up to six months (Horton & Hocking, 1999). 
 
Determinant factors of the critical period for visual cortical plasticity 
 
A further question for understanding how experience modulates neural circuits 
during critical periods is how patterns of activity are transduced to modify neural 
connections and to make these changes permanent. The ability of the central nervous 
system to process external stimuli into long term changes rely on activity dependent 
neural mechanisms that induce structural and functional modifications which underlie, 
for instance, processes of learning and memory. Extensive research during the last years 
shed light on determinant aspects of critical periods for experience-dependent plasticity. 
The mechanisms that modulate neural circuits functioning and connectivity rely on 
signals generated by the synaptic activity associated with sensory experience or motor 
performance, the basic neural processes by which experience is represented. A number of 
different signaling molecules, including NMDA receptors, neurotrophic factors, the 
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activity of the CRE-CREB system, extracellular matrix molecules and the GABAergic 
inhibitory transmission have been recognized as important regulators of visual cortical 
plasticity through changes that occur with correlated neural activity (reviewed by Berardi 
et al., 2003).  
  
Glutamatergic NMDA receptors 
 
Experimental evidence for the role of NMDA receptors in the regulation of visual 
cortical plasticity first came from the finding that blockade of such receptors inhibits the 
effects of monocular deprivation (Bear et al., 1990). The use of NMDA receptors 
antagonists and antisense oligonucleotides to reduce the expression of the NR1 subunit, 
without affecting visually driven activity, confirmed this notion (Roberts et al., 1998; 
Daw et al., 1999), demonstrating the NMDA receptor involvement in visual cortical 
plasticity. Additionally, the expression of NMDA receptors is developmentally regulated 
and modified by electrical activity. Their subunit composition varies in the visual cortex, 
from an increased expression of NMDA receptors containing the 2B subunit to a high 
presence of receptors containing the subunit 2A, with a time course that nearly parallels 
that of the functional development of the visual cortex. The expression of the NR2A 
subunit also correlates with the progressive diminishment of NMDA mediated currents 
(Flint et al., 1997). Dark rearing, which delays the critical period closure and impairs 
functional properties of the visual cortex, delays both the developmental shortening of 
NMDA receptor currents and expression of the NR2A subunit, suggesting a possible role 
for the 2B-to-2A switch in the closure of the critical period (Philpot et al., 2001). 
Nevertheless, experimental evidence against a causal role of NMDA receptors in 
determining the closure of the critical period comes from the finding that transgenic mice 
engineered to maintain prolonged NMDA responses by deletion of the NR2A subunit, 
show an unaltered sensitivity to MD which was restricted to the typical critical period and 
normally delayed by dark rearing from birth  (Fagiolini et al., 2003). Moreover, western 
blot analysis confirmed a late postnatal onset of NR2A protein expression in wild type 
animals (P18) well in advance of the critical period (P28). Taken together, these 
observations indicate that the late onset and experience-dependent profile of NR2A 
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subunits, known to determine LTP occurrence in the hippocampus, is not relevant for 




Experimental evidence that link neurotrophins and neuronal plasticity, particularly 
in the neocortex and hippocampus, came out in the 1990s. One of the first evidences 
regarding neurotrophic factors and visual cortical plasticity came from the work of 
Maffei et al., in 1992, who demonstrated that the physiological shift in ocular dominance 
distribution could be prevented by infusion of the nerve growth factor (NGF) into the 
cortex during the critical period. Later, Cabelli et al., in 1995, evidenced that infusion of 
BDNF and the neurotrophin 4/5 (NT4/5) during the critical period, but not NGF, 
prevented the formation of ocular dominance columns in the cat visual cortex; finding of 
importance not only because it showed that neurotrophins modulate the patterning of 
projections within the visual cortex, but also because it suggested that thalamic axons 
compete for limiting amounts of neurotrophic factors.  
Although plausible, such experiments, did not address the role of neurotrophins in 
activity dependent plasticity, since the effects observed still could be explain by a growth 
promoting action of BDNF and NT4/5 on thalamic axons within layer IV of the cortex, 
independent of neuronal activity. The requirement of neuronal activity for the occurrence 
of BDNF effects was evidenced by McAllister et al., in 1996, who demonstrated that 
inhibition of spontaneous electrical activity, glutamatergic synaptic transmission or 
inhibition of activation of L-type Ca2+ channels, prevented the BDNF induced dendritic 
growth in the visual cortex.  
In addition, the requirement of electrical activity for the occurrence of the effects 
induced by NGF on ocular dominance plasticity has also been demonstrated. It was tested 
in animals subjected to complete monocular blockade of retinal discharges through 
intravitreal tetrodoxin (TTX) injections, at the peak of the critical period, while NGF was 
concurrently delivered into the visual cortex by osmotic minipumps. Analysis of single 
cell recordings revealed that while infusion of NGF is effective in preventing the ocular 
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dominance shift in young monocularly deprived rats, no rescue can be observed in TTX 
injected animals intracortically infused with NGF (Caleo et al., 1999).  
 Striking evidence for the role of BDNF in regulating the critical period for visual 
cortical plasticity came from studies performed in transgenic mice overexpressing BDNF 
in the visual cortex, with no alterations in the normal cellular pattern of expression or 
release and an effectively restricted expression of the neurotrophin in excitatory 
neocortical neurons (Huang et al., 1999). In these animals BDNF overexpression 
accelerates both the development of visual acuity and the time course of ocular 
dominance, thus supporting a crucial role for neurotrophins in visual cortical 
development and plasticity. The reciprocal regulation between neurotrophins and 
electrical activity seems to provide a mechanism by which active neuronal connections 
are selectively strengthened. As mentioned before, neurotrophins seem to require the 
presence of electrical activity to exert their actions (Sala et al., 1998; Caleo et al., 1999). 
Indeed, it has been demonstrated that both weak synaptic plasticity and localized BDNF 
application, which by themselves do not alter synaptic efficacy, induces long-term 
potentiation of synaptic transmission (Kovalchuk et al., 2002), finding that suggest a 
synergistic effect of neurotrophins and electrical activity in promoting synaptic plasticity. 
Accordingly, although BDNF promotes the phosphorylation of the transcription factor 
cAMP-response-element binding protein (CREB), it evokes only weak CREB mediated 
gene transcription unless it is coupled with electrical activity (Hu et al., 1999).  
 
Activity of the CRE-CREB system 
 
The initial molecular events of neural plasticity, which are changes in synaptic 
efficacy that do not require protein synthesis, are followed by long-lasting changes in 
neural circuitries that depend on gene expression and subsequent synthesis of proteins 
(reviewed in Berardi et al., 2003). The intracellular signaling pathways underlying the 
integration of electrical activity and neurotrophin transmission, for instance, involve the 
activation of three different protein kinases: cAMP-dependent protein kinase (PKA), 
extracellular-signal-regulated kinase (ERK1/2) and Ca2+/calmodulin-dependent protein 
kinase II (CaMKII), whose activity is necessary for the shift of ocular dominance after 
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monocular deprivation in young animals (Taha et al., 2002; Di Cristo et al., 2001; Beaver 
et al., 2001). Each kinase is activated by specific patterns of extracellular signals and is 
tightly woven within a network of mutual interactions. Activation of such intracellular 
pathways leads to changes in gene expression mediated by an up-regulation of 
transcription factors like egr1/zif68 and CREB, and subsequent protein synthesis, as 
demonstrated for ocular dominance plasticity in the visual cortex (Mower et al., 2002). 
Activated kinases must translocate to the nucleus where they phophorylate CREB, which 
then initiates the expression of genes under control of the cAMP-response element (CRE) 
promoter. Then, the consequent production of transcripts essential for establishment and 
maintenance of plasticity, does take place (reviewed by Silva et al., 1998).  
 A critical role for the CRE-CREB system in regulating the expression of genes 
involve in the physiological plasticity events during postnatal neocortical development, 
using transgenic mice carrying a CRE-lacZ reporter, has been demonstrated as well 
(Pham et al., 1999). It was found that calcium- and cAMP-regulated signaling pathways 
in visual cortical neurons are activated by monocular deprivation in young animals, 
events that precede the plastic modification typically observed after manipulations of 
visual stimuli early in development. Indeed, immunofluorescence analysis of visual 
cortical sections of CRE-lacZ transgenic mice monocularly deprived during the critical 
period, demonstrated an increased number of lacZ-positive cells in the visual cortex 
contralateral to the deprived eye. Moreover, the induction of these molecular events was 
dramatically down-regulated following the end of the critical period for visual cortical 
plasticity (Pham et al., 1999). These results show that CREB mediated gene expression is 
involved in the occurrence of visual cortical plasticity during development and suggest 
that a reduction in the activity of the CRE-CREB system may be implicated in the decline 
of plasticity observed during late postnatal development.           
 
Extracellular matrix molecules 
 
A correlation between the extracellular environment and adult visual cortical 
plasticity has also been demonstrated. There is evidence indicating that removal of 
important components present in the extracellular environment of the central nervous 
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system is necessary for experience-dependent plasticity to take place. The extracellular 
protease tissue plasminogen activator (tPA), for instance, is induced by electrical activity 
as an immediate early gene (Qian et al., 1993) and its proteolytic activity in the visual 
cortex is increased during monocular deprivation (Mataga et al., 2002). Initial evidence 
for the role of tPA in visual cortical plasticity came from the work of Mataga et al., in 
1996, with the finding that its pharmacological inhibition attenuates the ocular dominance 
shift induced by monocular deprivation in young animals. This finding was then 
confirmed through pharmacological studies of the effects of monocular deprivation on 
tPA-knockout mice. Ocular dominance plasticity in these mice is impaired and can be 
rescued by exogenous tPA administration (Mataga et al., 2002). tPA has a wide spectrum 
of possible molecular targets, including extracellular matrix proteins (Wu et al., 2000), 
growth factors (Yuan et al., 2002), membrane receptors and cell adhesion molecules 
(Endo et al., 1999) which suggest an important role for this protease in visual cortical 
plasticity. 
Additional data confirming the inhibitory action of the extracellular environment 
on visual cortical plasticity came from the work of Pizzorusso et al., in 2002, which 
focused on a class of glycoproteins that are major components of the extracellular matrix, 
the chondroitin-sulphate proteoglycans (CSPGs). Such molecules are composed of a core 
protein and CSPG glycosaminoglycan chains, which show a wide expression in the 
central nervous system, where they give a structural support to the extracellular 
environment acting mainly as physical barriers (Faissner & Steindler, 1995). CSPGs 
typically condense in lattice-like structures designated as perineuronal nets (PNNs) 
during postnatal development (Hockfield et al., 1990; Bruckner et al., 2000), and 
completely ensheath inhibitory interneurons assuming a perisynaptic localization at sites 
of synaptic contacts (Zaremba et al., 1989; reviewed by Celio et al., 1998). In a set of 
very elegant experiments, Pizzorusso et al. (2002) showed that the developmental 
maturation of the extracellular matrix was inhibitory for experience-dependent plasticity 
in the visual cortex. The authors used immunohistochemical analysis for Wisteria 
Floribunda Agglutinin (WFA), which binds to CSPG glycosaminoglycan chains, to 
demonstrate that the formation of adult-like PNNs around inhibitory interneurons 
coincided with the end of the critical period. Then, they showed that rearing animals in 
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complete darkness from birth, a strategy that is known to prolong the critical period for 
ocular dominance plasticity (see Berardi et al., 2000), inhibits the developmental 
maturation of PNNs. Soon after, the authors analyzed the effects of CSPGs degradation 
in vivo with the enzyme chondroitin ABC (chABC) on visual cortical plasticity. This 
treatment caused a degradation of PNNs in the adult visual cortex and reactivated 
plasticity for ocular dominance in monocularly deprived adult rats, demonstrating that 
developmental maturation of PNNs contribute to the progressive reduction of plasticity 
that occurs in the visual cortex at the end of the critical period.  
That degradation of extracellular matrix components is a useful strategy to 
promote structural and functional recovery from visual deficits in the adult visual cortex, 
was recently demonstrated by Pizzorusso et al. (2006). In this case, long-term 
monocularly deprived animals were subjected to reverse suture in parallel to intracortical 
injections of the enzyme chABC which digest glycosaminoglycan chains of CSPGs, and 
single-unit recordings were then performed. The electrophysiological analysis showed a 
complete recovery of ocular dominance distribution in the visual cortex contralateral to 
the long-term deprived eye in chABC treated animals. Moreover, full recovery of both 
visual acuity and receptive field size of the long-term deprived eye was shown to be 
induced by chABC treatment. Thus, the authors demonstrated that intracortical infusion 
of chABC, coupled to reverse lid-suturing, favored the recovery of vision in adult rats 
with normal visual functions permanently impaired after long-term monocular 
deprivation.  
A critical role for myelin-associated proteins in adult visual cortical plasticity,  
which include ligands for the Nogo receptor (NgR) has also been recognized. In 
particular, some proteins that are components of the myelin sheath including Nogo and 
the myelin basic protein (MBP) have been found to be chemo-repulsive for growing 
axons. Indeed, such molecules display an important function during development of the 
central nervous system in mediating axon growth and guidance (Purves et al., 2004). In 
addition, axon growth inhibition after injury of the adult nervous system appears to 
reflect the activity of inhibitory signals produced by glia and other cells at the lesion site 
through NgR signaling.  
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As the vast majority of visual cortical neurons express the NgR, McGee et al. 
(2005) evaluated whether the NgR-mediated myelin inhibition of neurite outgrowth 
contributes to the closure of the critical period for ocular dominance plasticity in rodents. 
Initially, the authors demonstrated that maturation of intracortical myelination correlates 
with the end of the critical period. Afterwards, they used transgenic mice lacking the NgR 
to investigate the involvement of NgR-signaling in restricting OD plasticity in the 
adulthood. Analysis of adult NgR transgenic mice, well after the end of the critical period 
(P120), showed that OD plasticity persisted into adulthood since an OD shift of visual 
cortical neurons was elicited by MD. Moreover, it was demonstrated that transgenic mice 
lacking main ligand of the NgR: Nogo, showed a similar susceptibility to MD in the 
adulthood thus confirming that NgR-dependent mechanisms participate directly in 
restricting visual cortex experience-dependent plasticity (McGee et al., 2005).              
 
Intracortical GABAergic inhibition 
      
 It has become clear that inhibition has an important role in sculpting patterns of 
electrical activity. This action contributes to the detection of imbalance of activity 
between the afferents to single cortical neurons. A failure in the timing of arrival of 
synaptic inputs on a post-synaptic neuron has been correlated with a failure in plasticity. 
The fact that manifestation of visual cortical plasticity requires inhibitory transmission 
was first shown by Hensch et al. (1998), using transgenic mice lacking the 65-Kda 
isoform of the GABA-synthesizing enzyme GAD (GAD65). Experience dependent 
plasticity in young animals in response to monocular deprivation, is impaired in these 
transgenic mice. Normal plasticity in these animals is rescued by enhancement of 
GABAergic transmission, in the visual cortex, by means of benzodiazepines 
administration. Thus, if the intracortical inhibition is reduced in young animals, the 
critical period onset is delayed, suggesting that there is an inhibitory threshold to be 
surpassed before the critical period can start. In contrast, if the intracortical inhibition is 
precociously enhanced by diazepam administration (Fagiolini & Hensch, 2000) the 
critical period starts earlier. 
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It has also been demonstrated that the time course and closure of the critical 
period for visual cortical plasticity is mediated by the maturation of intracortical 
inhibition, which involves BDNF expression. The development of intracortical inhibition, 
indeed, is accelerated in BDNF overexpressing mice (Huang et al., 1999) which suggest 
that BDNF controls the time course of the critical period by accelerating the maturation 
of the GABA-mediated inhibition. It is known that intracortical inhibition provides strong 
control over activity-dependent synaptic plasticity (Artola & Singer, 1987; Kirkwood & 
Bear, 1994) and matures slowly in comparison to excitation. It has been suggested that 
such a developmental mismatch between inhibition and excitation provides a temporal 
window for the critical period, when the organization of neuronal circuitries can be 
strongly influenced by sensory experience. Thus, the maturation of intracortical 
inhibitory circuitries sets the threshold for both the start and the end of the critical period. 
Consistent with this notion, dark rearing which prolongs the closure of the critical period 
also delay the development of intracortical inhibition (Fagiolini et al., 1994; Benevento et 
al., 1992).   
 The use of in vitro models of neuronal plasticity, long-term potentiation and long-
term depression (LTP/LTD) of neural transmission, has also shed light on the molecular 
mechanisms underlying activity-dependent modifications of synaptic plasticity that 
depend on intracortical inhibition. In particular, reliable LTP of synaptic responses in 
layer II/III can be elicited by theta burst stimulation of layer IV in visual cortical slices of 
both young and adult animals. In contrast, LTP in layer II/III after electrical stimulation 
from the white matter (WM-LTP) can be obtained only in slices from the visual cortex of 
young rats but not in those of adult animals. Kirkwood & Bear (1994) first suggested that 
the maturation of inhibitory circuitries in layer IV is one of the mechanisms responsible 
for the closure of the critical period for the occurrence of WM-LTP. Indeed, theta burst 
stimulation from the white matter, in the adult rat, failed to induce LTP unless a GABAA 
receptor antagonist was applied to visual cortical slices. Notably, susceptibility to WM-
LTP roughly coincides with the critical period for ocular dominance plasticity and, as the 
critical period, can be prolonged by dark rearing (Kirkwood et al., 1995). In support to 
this hypothesis, BDNF overexpressing mice, which show an accelerated maturation of 
intracortical inhibition, displayed an accelerated developmental decline of WM-LTP in 
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the visual cortex. The magnitude of LTP in wild-type mice undergoes a sharp decline 
between the fourth and fifth postnatal weeks, whereas in transgenic mice such decline in 
LTP occurred one week earlier (Huang et al., 1999). Moreover, it has also been 
demonstrated that WM-LTP can be rescued by blocking intracortical inhibition in slices 
derived from BDNF transgenic mice. 
 As to the diversity of intracortical inhibitory networks involved in the occurrence 
of plasticity in the visual cortex, the use of transgenic knockin animals with mutations in 
particular α-subunits of GABAA receptors, has given the opportunity to analyze whether 
specific GABA circuitries underlie plasticity in the visual system (Fagiolini et al., 2004). 
Because specific GABAA receptor-mediated currents can be enhanced by certain 
benzodizepines, whose sensitivity is determined by particular α-subunit composition, the 
triggering of ocular dominance plasticity through cortical administration of the 
benzodiazepine diazepam in parallel to monocular deprivation in young animals with 
point mutations in the α-1 α-2 and α-3 subunits that contribute to the benzodiazepine 
binding site, showed that only α1-containing inhibitory GABAergic circuitries regulate 
the expression of the critical period for visual cortical plasticity. In particular, point 
mutations of a histidine (H) to an arginin (R) in different subunits: α-1(H101R), α-
2(H101R) and α-3(H101R), which renders individual GABAA receptors insensitive to 
diazepam, were used. The authors initially showed that wild-type mice (in which 
normally no plasticity occurs after brief monocular deprivation soon after eye opening) 
that were cortically treated with the benzodiazepine agonist zoldipem, showed a marked 
ocular dominance shift in favor of the non deprived eye. Afterwards, they went on to 
examined ocular dominance plasticity in α-1(H101R) animals and found that no shift of 
ocular dominance occurred after cortical infusion of diazepam in parallel to brief 
monocular deprivation. In contrast, α-2(H101R) animals displayed an ocular dominance 
shift of visual cortical neurons similar to that of control animals after benzodiazepine 






Visual Evoked Potentials (VEPs) and visual acuity 
 
 The visual evoked potentials (VEPs) in response to sinusoidal gratings alternated 
in phase several times per sec have proved to be very useful for the study of visual 
functions in man and animals. The extensive application of this technique is based on the 
fact that it does allow to predict either the psychophysical contrast sensitivity or limit of 
spatial resolution. Indeed, extrapolation to zero amplitude of the regression line obtained 
by plotting VEP amplitude against log contrast or log spatial frequency of the stimulus 
grating, gives contrast sensitivity or visual acuity values which are very similar to the 
psychophysical estimations (Campbell & Maffei, 1970). This has been evidenced not 
only in man but also in other animal species in which the subjective contrast thresholds or 
acuity estimations were behaviorally evaluated (Campbell et al., 1973; Nakayama & 
Mackeben, 1982). Because of the coincidence between contrast threshold estimated from 
psychophysical and from electrophysiological data, VEPs are assumed to be a reliable 
technique used to predict the subjective contrast sensitivity in all those cases in which 
other techniques are difficult to apply (Maffei & Fiorentini, 1990). 
  The pattern-reversal VEPs have also been useful to study the postnatal 
development of visual contrast sensitivity in infants (Pirchio et al., 1978) and to 
investigate the physiological mechanisms underlying the processing of spatial 
information in man as well. In particular, evidence has been found supporting the 
existence in the human visual cortex of orientation channels (Maffei & Campbell, 1970) 
and of spatial frequency channels (Fiorentini et al., 1983). In addition, methods based on 
the recording of pattern VEPs have been successfully applied in infants to study the 
postnatal development of orientation and spatial frequency selectivity (Fiorentini et al., 
1983). Moreover, VEP techniques have become an important tool in clinical practice both 
in adults and young children with neurological diseases.  
 Initial studies aimed at identifying the site of origin of the pattern reversal VEP 
suggested that pre- and post-synaptic mechanisms very likely contributed to VEPs 
(Maffei & Fiorentini, 1990). The contribution of post-synaptic components in the 
generation of VEPs is highlighted by the fact that VEPs share some of the properties of 
visual cortical cells such as, for instance, orientation selectivity (Hubel & Wiesel, 1962) 
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and susceptibility to contrast adaptation (Maffei et al., 1973). These are properties that 
are not found in the lateral geniculate nucleus or the retina.  
As to the dependence upon stimulus orientation, the amplitudes of VEPs recorded 
in man has been found to be larger for horizontal and vertical gratings than for oblique 
ones (Maffei & Campbell, 1970). In the cat, orientational interactions between grating 
stimuli have been observed in VEP responses. Other properties of visual cortical neurons 
that have been shown to be shared by VEPs, are the adaptation after impairments of 
contrast sensitivity following the observation of high-contrast gratings, which has been 
shown to occur both in man and animals as well as cross orientation inhibition, i.e., 
inhibition of the response to a phase-reversed grating by a superimposed orthogonal 
grating (Morrone & Burr, 1986). As to the nature of the post-synaptic neuronal events 
that contribute to the pattern VEP, these are likely to consist mainly of source-sink pairs 
related to excitatory post-synaptic potentials. The spike activity of individual neurons 
seems not to contribute to the occurrence of VEPs (Petsche et al., 1984). 
 Another characteristic property of steady-state pattern reversal VEPs is that their 
waveform has a temporal frequency that corresponds to the second harmonic of contrast 
orientation, at least for temporal frequencies of 10-20 reversal per sec. In the visual 
cortex this is a property of complex cells, which are neurons that present orientation 
selectivity. Simple cells, in contrast, respond to phase-reversal gratings with a modulation 
of their discharge mainly at the fundamental temporal frequency of the stimulus. This, 
however, does not rule out the possibility that simple cells contribute to the generation of 
steady-state VEPs. Indeed, the response of a simple cell is not a pure fundamental; it also 
contains the second and higher harmonics although with a much smaller amplitude. Thus, 
when the response of a large population of cells adds up, the first and the higher odds 
harmonics cancel out but the second harmonics responses do not. Therefore, the steady 
state VEPs in response to alternating gratings could reflect the activity of both complex 
and simple cells (Maffei & Fiorentini, 1990). 
 VEPs have also been used to characterize the physiology of the visual system in 
rodents (Porciatti et al., 1999). Through electrophysiological recordings from the primary 
visual cortex of the wild-type C57BL/6J mouse, the authors evaluated spatial and 
temporal aspects of VEPs. In particular, the mouse VEP limit of spatial frequency (visual 
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acuity) was found to be 0.6 c deg─1 an estimated value that was comparable to the 
behavioral visual acuity. VEPs recordings at different depths of the binocular portion of 
the visual cortex contralateral to the stimulated eye also revealed that the VEP major 
component is positive in the superficial layers, whereas in deeper layers it is negative. 
Local VEPs had their maximal amplitude about 400 μm of depth in the cortex, which 
correspond to the termination of geniculate afferents at the level of cortical layer IV 
(Porciatti et al, 2002). Importantly, this pattern of VEPs depth profile is very consistent 
among animals. That the intracortical VEP profile shows a clear polarity inversion at a 
point between 150 and 200 μm electrode advancement, suggest a major dipole source of 
VEPs located at this cortical level. Indeed, anatomical reconstruction of electrode tracks 
indicates that the major dipole source is generated at the level of pyramidal cells in 
supragranular layers II-III of the visual cortex (Porciatti et al., 1999). 
Electrophysiological recordings of VEPs also provide the advantage that different aspects 
of vision can be screened readily and simultaneously in the same animals, including those 
with poor visual behavior due to motor or learning deficits.       
     
Functional development of the rat primary visual cortex 
 
Early electrophysiological studies in the adult visual system of the rat found that 
cortical neurons have well defined functional properties (Parnavelas et al., 1981; Maffei 
et al., 1992) and are distributed in distinct classes of ocular dominance, with high 
proportion of binocular cells, comparable to that in cats and monkeys (Maffei et al., 
1992; Berardi et al., 1993). The functional postnatal development of the rat primary 
visual cortex was initially investigated by Fagiolini et al., in 1994. The authors 
demonstrated that physiological properties of visual cortical neurons are immature soon 
after eye opening, and gradually develop during the first month of postnatal life. Visual 
cortical responses are slow and variable at P17, particularly, they present habituation 
which is the tendency of cell response to diminish after continues stimulation. Neuron 
responsiveness, evaluated as amplitude of modulation of cell discharge in response to an 
optimal visual stimulus, increases progressively with age over the third postnatal week, 
while the sluggishness and tendency to habituation disappears by P23. Ocular dominance 
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distribution does not change significantly through development; indeed the vast majority 
of visual cortical neurons are binocular and preferentially driven by the contralateral eye. 
The major component of age dependent changes in ocular dominance distribution is the 
increase of monocular, contralateraly driven cells. Receptive fields in adult rats are small 
and well defined, but this is not the case in younger animals, in which receptive fields at 
P17 are very large, extending through almost the whole binocular hemifield. At P19-21 
receptive field size is around 34 degrees (deg), and it reaches the value of 10 deg or less 
in the adult. Similarly, visual acuity, which is the highest spatial frequency that can be 
perceived, increases from 0,5 c deg─1 to 0,9 c deg─1 within the first month of life in the rat 
and then reaches the value of about 1 c deg─1 in the adult at P45 (Fagiolini at al., 1994).  
Importantly, a precocious development of visual acuity has been shown to occur 
in mice overexpressing the neurotrophin BDNF (Huang et al., 1999). In these transgenic 
mice adult levels of visual acuity were reached precociously, at about P25, one week 
earlier than that of wild-type littermates. On the other hand, there is evidence that the 
progressive decrease in receptive field size is correlated with the time course of visual 
acuity development (Fagiolini at al., 1994). Therefore, one plausible mechanism by 
which increased levels of BDNF would accelerate such property of visual cortical 
neurons is the acceleration of inhibitory circuitries maturation, which by affecting 
receptive field development, could promote the faster maturation of visual acuity. 
 In support to this notion, an accelerated development of visual acuity has also 
been evidenced in animals under environmental enrichment conditions. This is a 
condition characterized by an increased exploratory behavior, somatosensory and social 
stimulation which is known to increase the expression of BDNF and promote a 
precocious maturation of intracortical inhibition in young animals (Cancedda et al., 2004; 
Sale et al., 2004). As in the case of BDNF overexpressing mice, environmental enriched 
pups also show a precocious developmental decline of WM-LTP, which is an in vitro 






Visual deprivation and amblyopia in humans
 
During development, the cortical representation of both eyes starts out equal and 
in a normal animal this balance is retained if both eyes experience roughly comparable 
levels of visual stimulation. When, however, an imbalance in visual experience is 
induced by monocular deprivation, the active eye gains a competitive advantage and 
replaces many of the synaptic inputs from the closed eye, such that few if any neurons 
can be driven by the deprived eye. Thus, an acquired defect in vision due to an abnormal 
visual experience during a sensitive period of visual development that is characterized by 
reductions in visual acuity and contrast sensitivity, does take place (Grigg et al., 1996). 
These observations in experimental animals have important implications for children with 
birth defects or ocular injuries that cause an imbalance of inputs from the two eyes. 
Unless the imbalance is corrected during the critical period, the child may ultimately have 
visual functions permanently impaired, as evidenced by poor binocularity, diminished 
depth perception, and reduced visual acuity (see Levi et al., 1997).  
The developmental phenomena in the visual system of experimental animals are 
in agreement with clinical problems in children who have experienced similar 
deprivation. The loss of visual acuity and diminished stereoscopic vision that arise from 
early deficiencies of visual experience is called “amblyopia”. In humans, amblyopia is 
most often the result of strabismus, a misalignment of the two eyes due to improper 
control of the direction of gaze by the eye muscles (reviewed in Grigg et al., 1996).  
Since such misalignments produce double vision, the response of the visual system in 
some of these individuals is to suppress input from one eye by mechanisms that are not 
completely understood, but are thought to reflect competitive interactions during the 
critical period. Functionally, however, the suppressed eye eventually comes to have very 
low visual acuity and may render the affected individual effectively blind in that eye. 
Thus, early surgical correction of ocular misalignment, by adjusting lengths of extra-
ocular muscles, has become an essential treatment for children with strabismus (Purves et 
al., 2004). Another cause of visual deprivation in humans is cataracts which can be 
caused by several congenital conditions that render the lenses opaque. A cataract in one 
eye is functionally equivalent to monocular deprivation in experimental animals; left 
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untreated in children, this defect also results in an irreversible effect on the visual acuity 
of the deprived eye. If either the cataract or corneal opacity is removed at about 4 months 
of age, however, the consequences of monocular deprivation are largely avoided 
(reviewed by Holmes & Clark, 2006).  
In animal models, the role of correlated activity in driving the competitive 
postnatal rearrangement of cortical connections can be assessed inducing a situation in 
which activity levels in each eye remain the same but the correlations between the two 
eyes are altered. This circumstance can be obtained by cutting one of the extra-ocular 
muscles in one eye, condition known as strabismus in which the two eyes can no longer 
be aligned (Purves et al., 2004). The major consequence of strabismus is that 
corresponding points on the two retinas are no longer stimulated by objects in the same 
location in visual space at the same time. As a result, differences in the visually evoked 
patterns of activity between the two eyes are far greater than normal. Unlike monocular 
deprivation, however, the overall amount of activity in each eye remains roughly the 
same; only the correlation of activity arising from corresponding retinal points is 
changed. Misalignment of the two eyes can lead to suppression of the input from one eye 
and eventual loss of the related cortical connections. The anatomical pattern of ocular 
dominance columns in layer IV of cats in which input from both eyes remains (but is 
asynchronous) is sharper than normal, implying that the uncoordinated patterns of 
activity have accentuated the normal separation of cortical inputs from the two eyes. In 
addition, the ocular asynchrony prevents the binocular convergence that normally occurs 
in cortical neurons: ocular dominance histograms from such animals show that most cells 
in all layers are driven exclusively by one eye or the other (Hubel & Wiesel, 1965).  
Even before visual experience exerts these effects, innate mechanisms have 
ensured that the basic outlines of a functional system are present. These intrinsic 
mechanisms establish the general circuitry required for vision, but allow modifications to 
accommodate the individual requirements that occur with age (Crawley & Katz, 2002). 
Normal visual experience validates the initial wiring, preserving and adjusting the normal 
arrangement. In the case of abnormal experience, the mechanisms that allow these 
adjustments result in more dramatic anatomical and ultimately behavioral changes, such 
as those that occur in amblyopia. The eventual decline of this capacity to remodel cortical 
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and subcortical neuronal connections is presumably the cellular basis of critical periods in 
a variety of neural systems, including the development of language and other higher brain 
functions. 
 
Aim of the thesis and experimental design 
 
 Recent experimental evidence suggests a critical role for neuronal plasticity in 
mediating the therapeutic effects induced by ADs. It has been observed that chronic 
antidepressant administration promotes neurogenesis and synaptogenesis in the adult 
hippocampus (Malberg et al., 2000; Hajszan et al., 2005) as well as an increased 
expression of the neurotrophin BDNF and its primary receptor TrkB (Nibuya et al., 1995; 
Castren et al., 2004). These cellular and molecular events seem to be necessary in 
mediating the therapeutic effects of ADs. The antidepressant-like behavioral response to 
ADs, indeed, is blocked if the induced neurogenesis is disrupted (Santarelli et al., 2003) 
whereas direct infusion of BDNF into the hippocampus, or the overexpression of its 
receptor in transgenic mice, induce an antidepressant effect (Shirayama et al., 2002; 
Koponen et al., 2005). While neurogenesis, synaptogenesis and BDNF signaling are 
events that correlate with neuronal plasticity, whether ADs promote a functional 
modification of neuronal circuitries, is currently unknown.  
In the present study we investigated whether chronic treatment with fluoxetine, a 
selective serotonin reuptake inhibitor (SSRI), restores plasticity in the adult visual system 
of the rat. We used two well characterized models of plasticity, the ocular dominance 
(OD) shift of visual cortical neurons following monocular deprivation (MD) and the 
recovery of visual functions in the adult after long-term MD (amblyopia). These two 
plastic phenomena are restricted to a critical period during postnatal development and are 
absent in the adult because of a decline of plasticity that has been largely attributed to the 
maturation of intracortical inhibition (Huang et al., 1999; Fagiolini & Hensch, 2000). A 
shift in the composition of NMDA receptor subunits (Erisir & Harris, 2003), the activity 
of the CRE-CREB system (Pham et al., 1999), and the condensation of extracellular 
matrix molecules in perineuronal nets mainly around inhibitory interneurons (Pizzorusso 
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et al., 2002), are cellular events which have been correlated to the closure of the critical 
period for visual cortical plasticity as well.   
 In particular, we investigated the effects of monocular deprivation (MD) on the 
ocular dominance (OD) plasticity of adult animals chronically treated with fluoxetine, by 
recording VEPs in the binocular region of the primary visual cortex contralateral to the 
deprived eye. We next used VEPs to evaluate the recovery of visual acuity and 
binocularity in adult rats that were rendered amblyopic by long-term MD and then 
reverse-sutured (RS) during the last two weeks of antidepressant treatment. Recovery of 
visual acuity was also evaluated behaviorally in the same animals.   
 Afterwards, we used in vivo brain microdialysis to investigate whether chronic 
fluoxetine administration affected the ratio of intracortical inhibition relative to excitation 
in the adult visual cortex. In addition, long-term potentiation of layer II-III field 
potentials after theta-burst stimulation from the white matter (WM-LTP), an in vitro 
model of synaptic plasticity, was also examined. BDNF protein expression in the visual 
cortex and hippocampus of adult rats chronically treated with fluoxetine was assessed 
using the ELISA method. Western blot analysis of GAD65/67 expression following 
antidepressant treatment was performed as well. 
We finally evaluated the effects of fluoxetine on visual cortical plasticity in adult 
animals monocularly deprived in parallel to intracortical infusion of the benzodiazepine 
agonist diazepam. The antidepressant-like behavioral response produced by fluoxetine 














Animal treatment and fluoxetine administration  
 
A total of 76 adult Long-Evans hooded rats were used in this study, which was 
approved by the Italian Ministry of Public Health. Animals were group-housed under 
standard conditions with food and water ad libitum in plexiglas cages (40x30x20 cm) and 
kept in a 12:12 light/dark cycle. Adult rats at the postnatal day 70 (P70) were 
systemically treated with fluoxetine (0.2 mg ml–1 drinking water) (Fluoxetine-
hydrochloride, Galeno, Prato-Italy) during 04 weeks (28 Days). Control animals were 
housed under the same standard conditions except for fluoxetine administration. This 
method of administration yields fluoxetine plasma levels of 356 ± 99 ng ml–1 in rats, 
which is within the recommended plasma concentration for the treatment of depression in 




To assess ocular dominance (OD) plasticity, one week of monocular deprivation 
(MD) was performed through eyelid suturing at the beginning of the last week of chronic 
fluoxetine or vehicle administration (Day 21 of treatment). Adult animals (P90), under 
treatment, were anesthetized with avertin (1 ml hg–1) and mounted on a stereotaxic 
apparatus to be monocularly deprived. Eyelid closure was inspected daily until complete 
cicatrization; subjects with even minimal spontaneous re-opening were excluded. Great 
care was taken during the first days after MD to prevent inflammation or infection of the 
deprived eye through topical application of antibiotic and cortisone. 
To perform analysis of long-term MD, rats were anesthetized with avertin (1 ml 
hg–1) and monocularly deprived through eyelid suturing at P21. Eyelid closure was 
inspected daily until complete cicatrization; subjects with even minimal spontaneous re-
opening were excluded. Adult amblyopic rats were then subjected to reverse suture (RS), 
under anesthesia, at the beginning of the third week (P85) of chronic fluoxetine or vehicle 
administration (Day 14 of treatment). Reverse suture (RS), i.e., reopening of the deprived 
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eye while suturing shut the previously open eye, was performed using thin scissors. Great 
care was taken during the first days after RS to prevent inflammation or infection in the 
previously deprived eye through topical application of antibiotic and cortisone. 
 
 In vivo electrophysiology  
 
At the end of chronic fluoxetine or vehicle administration, adult animals 
monocularly deprived for one week and long-term MD animals subjected to RS, were 
anesthetized with urethane (0.7 ml hg─1; 20% solution in saline; Sigma) by i.p. injection 
and placed in a stereotaxic frame. Additional doses of urethane were used to keep the 
anesthesia level stable throughout the experiment. Body temperature was continuously 
monitored and maintained at ~37°C by a thermostated electric blanket during the 
experiment. An electrocardiogram was continuously monitored. A hole was drilled in the 
skull, corresponding to the binocular area of the primary visual cortex (Oc1B) 
contralateral to the deprived eye. After exposure of the brain surface, the dura was 
removed, and a micropipette (2 MΩ) filled with NaCl (3 M) was inserted into the cortex 
5 mm from λ (intersection between sagittal- and lambdoid-sutures). Both eyes were fixed 
and kept open by means of adjustable metal rings surrounding the external portion of the 
eye bulb. We measured visual acuity through both eyes recording visual evoked 
potentials (VEPs) (Figure 5). During recording through one eye, the other was covered by 
a black adhesive tape. To record VEPs, the electrode was advanced at a depth of 100 or 
400 μm within the cortex. At these depths, VEPs had their maximal amplitude. Signals 
were band-pass-filtered (0.1–100 Hz), amplified, and fed to a computer for analysis, as 
described previously (Huang et al., 1999). Briefly, at least 128 events were averaged in 
synchrony with the stimulus contrast reversal. Transient VEPs in response to abrupt 
contrast reversal (0.5 Hz) were evaluated in the time domain by measuring the peak-to-
baseline amplitude and peak latency of the major negative component. Visual stimuli 
were horizontal sinusoidal gratings of different spatial frequencies and contrast, 
generated by a VSG2/2 card running custom software and presented on a monitor (20 x 
22 cm; luminance 15 cd m–2) positioned 20 cm from the rat’s eyes and centred on the 
previously determined receptive fields. Visual acuity was obtained by extrapolation to 
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zero amplitude of the linear regression through the last four to five data points in a curve 
where VEP amplitude is plotted against log spatial frequency. Binocularity (ocular 
dominance) was assessed calculating the contralateral to ipsilateral (C/I) VEP ratio, i.e. 
the ratio of VEP amplitudes recorded by stimulating the eye respectively contralateral 
and ipsilateral to the visual cortex where recording is performed. 
 
Figure 5. Schematic diagram of the Visual Evoked Potentials (VEPs). A, Visual stimuli are horizontal 
sinusoidal gratings of different spatial frequencies and contrast. B, Typical VEP waveform recorded from 
an electrode positioned 400 μm below the cortical surface. The response consists of a negative wave of 90-
100 ms latency followed by a late positive wave. C, The recording site for VEPs is the binocular region 
(Oc1B) of the primary visual cortex contralateral to the deprived eye.    
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 Behavioral assessment of visual acuity 
 
We measured visual acuity of the fellow eye (not deprived) in long-term 
monocularly deprived rats before performing RS, thus behavioral assessment of visual 
acuity for the normal eye started at the beginning of chronic treatment (P70). Next, we 
started measuring visual acuity of the formerly deprived eye (long-term deprived), after 
RS, at the beginning of the third week (P90) of chronic fluoxetine or vehicle 
administration (Day 14 of treatment). Therefore, visual acuity measurement of the 
formerly deprived eye was completed when animals were about P100, at the end of 
chronic fluoxetine or vehicle treatment. To measure visual acuity, we used the visual 
water task (Prusky et al., 2000) which trains animals to first distinguish a low (0.1 cycles 
per degree (c deg–1) spatial frequency vertical grating from grey, and then tests the limit 
of this ability at higher spatial frequencies. The apparatus consists of a trapezoidal-shaped 
pool with two panels placed side by side at one end (Figure 6). A midline divider is 
extended from the wide end of the pool into the middle, creating a maze with a stem and 
two arms. The length of the divider sets the choice point and effective spatial frequency. 
An escape platform is placed below the grating. Animals are released from the centre at 
the end of the pool opposite the panels. The position of the grating and the platform is 
alternated in a pseudorandom sequence over training trials while the rats are shaped to 
swim towards the grating in one of the maze arms. A trial is recorded as incorrect if an 
animal enters the arm without the platform. Animals are removed from the pool when 
they find the platform. Once 80% accuracy is achieved, the limit of the discrimination is 
estimated by increasing the spatial frequency of the grating. Visual acuity has been taken 
as the spatial frequency corresponding to 70% of correct choices on the sigmoidal 
function fitting the psychometric function. During each session, the experimenter was 













Figure 6. Schematic diagram of the visual water box task. A, Front view of the apparatus which is a 
trapezoidal-shaped pool with two panels placed side by side at one end. A midline divider is extended from 
the wide end of the pool into the middle, creating a maze with a stem and two arms. An escape platform is 




In vivo brain microdialysis 
 
One week before the initiation of the chronic fluoxetine or vehicle administration, 
adult rats (P60) were anesthetized and stereotaxically implanted with a guide shaft above 
the binocular visual cortex (binocular area Oc1B), at coordinates: 7.3 mm posterior to 
bregma, 4.4 mm lateral to the midsagittal suture and 1 mm ventral to the skull. After the 
end of chronic treatment with fluoxetine, the in vivo sampling of dialysates was 
performed inserting a microdialysis probe into the guide shaft previously implanted. A 
detailed description of the procedure is reported in (Hernandez et al., 1986) (Figure 7).  
 
Figure 7. Schematic diagram of in vivo brain microdialysis. Sampling of basal extracellular levels of 
neurotransmitters from the binocular area of the visual cortex in fluoxetine treated adult rats. The 
microdialysis probe is connected to a dialysis system pumping artificial CSF. After insertion of the probe 
into the guide shaft in vivo sampling of dialysates is performed in each freely moving animal. 
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The microdialysis probe (Custom BR 1mm probe, BASi Instruments LTD, UK) 
with a 1 mm long tip of exposed cellulose membrane (6000 MW cut-off) was connected 
to a dialysis system pumping an artificial CSF (142 mM NaCl, 3.9 mM KCl, 1.2 mM 
CaCl2, 1 mM MgCl2, 1.35 mM Na2HPO4 , pH 7.4) at a flow rate of 1 µl min–1. The probe 
protruded 1 mm from the tip of the guide shaft (Figure 8). Six hours after insertion of the 
probe (stabilization period), sampling was carried out. Six samples (20 µl/each) were 
collected every 20 min along 2 hours for each freely moving fluoxetine treated and 






Figure 8. Scheme of the microdialysis probe and diffusion of neurotransmitters (blue arrows) through the 
dialysis membrane. The probe permits the delivery of CSF directly into the visual cortex to sample levels 
of neurotransmitters, which diffuse from the neural tissue to the perfusion fluid into the probe, through the 








After brain microdialysis, rats were sacrificed with an overdose of chloral hydrate 
and perfused intracardially. Brains were post-fixed for two hours before being immersed 
in 30% sucrose in PBS. Forty (40) μm coronal sections from the occipital cortex were cut 
on a sledge microtome and collected in PBS. Brain sections were then stained for cresyl 
violet to verify probes’ location in Oc1B. Only those animals with a correct location of 
the probe were taken into account for further analysis. 
 
High Performance Liquid Chromatography (HPLC) 
 
Analysis of γ-aminobutyric acid (GABA) and glutamate (GLU) basal levels from 
microdialysates obtained from fluoxetine treated and control animals, was performed 
using High Performance Liquid Chromatography (HPLC) coupled to a fluorimetric 
detection system. A sample automatic derivatization (Waters 2690 Alliance) with o-
phtalaldehyde was followed (Calabresi et al., 1995). Resolution was obtained through a 
C18 reverse phase chromatographic column coupled to the fluorimetric detection (Waters 
474; excitation wavelength 350nm, emission wavelength recorder 450nm). Buffer and 
gradient program was as follows: by definition, solvent A: 0.1M Sodium Acetate pH 
5.8/methanol 20/80; solvent B: 0.1M Sodium Acetate pH 5.8/methanol 80/20; solvent C: 
0.1M Sodium Acetate pH 6.0/methanol 80/20. Concerning the gradient program, initial 
isocratic step 5%A, 95%C from 0 to 5 min; 15%A, 85%B from 4 to 5 min and then 
isocratic until 9 min; 22%A, 66%B until 14.5 min and then 34%A, 66% B until 17 min; 
5%A, 95%C until 19 min and then isocratic until 23 min. Flow rate was 0.9 ml min–1. 
Homoserine was used as internal standard and aminoacid concentrations were calculated 
from a linear standard curve built upon known concentrations of injected aminoacids. 








Brains from fluoxetine treated and control adult rats (P100) were removed and 
immersed in ice-cold cutting solution containing (in mM): 220 sucrose, 3.1 KCl, 1.0 
K2HPO4, 4.0 NaHCO3, 2.0 MgCl2, 1.0 CaCl2, 10 HEPES, 1.0 ascorbic acid, 0.5 myo-
Inositol, 2.0 pyruvic acid, and 1.0 kynurenate, pH 7.3. Slices (0.35mm thick) of visual 
cortex were obtained using a Leica (Nussloch, Germany) vibratome. Slices (n = 12 slices 
for fluoxetine treated animals and n = 14 slices for controls) were then perfused at a rate 
of 2 ml min–1 with 35°C oxygenated recording solution. The recording solution was 
composed of as the cutting solution with the following differences (in mM): 130 NaCl, 
5.0 dextrose, 1.0 MgCl2, 2.0 CaCl2, 0.01 glycine, no kynurenate, no sucrose. Electrical 
stimulation (100 µsec duration) was delivered with a bipolar concentric stimulating 
electrode (FHC, St. Bowdoinham, ME) placed at the border of the white matter and layer 
VI. Field potentials in layers II-III were recorded by a micropipette (1–3MΩ) filled with 
NaCl (3 M). Baseline responses were obtained every 30 sec with a stimulation intensity 
that yielded a half-maximal response. After achievement of a 15 min stable baseline 
(field potential amplitude within 15% of change and with no evident increasing or 
decreasing trends), θ burst stimulation (TBS) was delivered. Postsynaptic field potentials 




At the end of the chronic fluoxetine or vehicle administration the expression of 
the GABA synthesizing enzymes (GAD65/67) was assessed using Western Blot. Proteins 
from fresh visual cortex were extracted using lysis buffer (1% Triton X-100, 10% 
Glycerol, 20 mM TrisHCl pH 7.5, 150 mM NaCl, 10 mM EDTA, 0.1 mM Na VO , 1 ¼ 
g/ml Leupeptin, 1 ¼ g/ml Aprotinin, 1 mM PMSF) and the total concentration of samples 
was quantified with the protein assay kit (Bio-Rad, Hercules, CA) using a BSA based 
standard curve. Then, 10 µg of proteins were run 
3 4
on 12% SDS-PAGE gels to ultimately 
be electroblotted on nitrocellulose membranes. Blots were blocked with 4% dry milk 
powder (Bio-Rad Laboratories Inc., Hercules, CA), 0.2% Tween-20 in TBS for 2h and 
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incubated overnight at 4 °C with the polyclonal anti-GAD65/67 antibody (Chemicon, 
Temecula, CA) diluted at 1 µg ml–1 in TBS, 2% milk, 0.1% Tween-20. After washing, 
blots were incubated 1h at 37 °C with HRP-conjugated secondary antibody (Goat Anti 
Rabbit HRP; Bio-Rad, Hercules, CA), developed by ECL chemiluminescence’s system 
(Amersham, UK) and captured on autoradiographic films.  
To account for loading errors blots were then stripped with Re-Blot (Chemicon, 
Temecula, CA), blocked with 4% dry milk powder, 0.2% tween-20 in TBS for 2h and re-
probed overnight at 4 °C with the monoclonal anti-tubulin antibody (Tubulin, Sigma, 
St Louis, MO; diluted 1 µg/ml in TBS, 2% milk, 0.1% Tween-20). Soon after, blots were 
incubated with HRP-conjugated secondary antibody (Goat Anti Rabbit HRP; Bio-Rad, 
Hercules, CA) as above described. Films were digitalized and band optical densities (OD) 
relative to the proteins of interest, as well as, to the corresponding tubulin internal 
standards, were measured with the Image-J software. The ratio of protein/tubulin OD 
mean (± S.E.M.) values, corresponding to the visual cortex of a single animal, was 
calculated for each sample. 
 
Enzyme Linked ImmunoSorbent Assay (ELISA) 
  
The expression of the protein BDNF was assessed at the end of chronic fluoxetine 
or vehicle administration using the ELISA method. Proteins from fresh visual cortex and 
hippocampus were initially extracted, respectively, using lysis buffer (1% Triton X-100, 
10% Glycerol, 20 mM TrisHCl pH 7.5, 150 mM NaCl, 10 mM EDTA, 0.1 mM Na VO , 
1 ¼ g/ml Leupeptin, 1 ¼ g/ml Aprotinin, 1 mM PMSF). The total concentration of 
samples was quantified with the protein assay kit (Bio-Rad, Hercules, CA) using a BSA 
based standard curve. 
3 4
Afterwards, BDNF expression was assessed loading 100 µg of total 
proteins in triplicate in a standard ELISA plate together with a standard curve and 
processed as indicated in the manufacturer protocol (BDNF, Promega). Results are 





Cortical infusion of the benzodiazepine diazepam (Dz) 
 
At the beginning of the last week of chronic treatment with fluoxetine (Day 21 of 
treatment), a different group of adult rats was subjected to MD. In parallel, under 
anesthesia, an osmotic minipump (model 2002; Alzet, Palo Alto, CA) connected via PE 
tubing to a stainless steel cannula (30 gauge), was implanted in the visual cortex 
contralateral to the deprived eye. Osmotic minipumps (flow rate, 0.5 µl hr–1) were filled 
up with the benzodiazepine agonist diazepam (Dz; 2mg ml–1; n = 4) or vehicle solution 
(50% propylene glycol; n = 4). Soon after surgery, rats were transferred to standard 
condition cages and kept under fluoxetine treatment for one more week. 
Electrophysiological recordings of the C/I ratio by VEPs was performed at the end of 
antidepressant treatment as previously described.  
 
Cortical infusion of mercaptopropionic acid (MPA) 
 
A different group of adult (not-deprived) rats was cortically infused with MPA via 
an osmotic minipump (model 2002; Alzet, Palo Alto, CA) connected via PE tubing to a 
stainless steel cannula (30 gauge), which was implanted in the binocular region of the 
primary visual cortex. Osmotic minipumps (flow rate, 0.5 µl hr–1) were filled up with a 
non-epileptic dose of MPA (100 μM; n = 4) or vehicle solution (Saline; n = 4). Soon after 
surgery, rats were transferred to the cages and kept under standard conditions for one 
more week. Brains were then removed and proteins from fresh visual cortex were 










Rat Forced Swim Test 
 
Behavioural response to fluoxetine treatment was studied in adult rats (P100) 
chronically treated with fluoxetine and control animals, using the forced swim test which 
is sensitive to the antidepressant activity of SSRIs (Cryan and Lucki, 2000). Briefly, rats 
were individually placed in a glass container (30 x 40 cm) that was filled with water at 22 
°C to a depth of 30 cm, in the first day session (Figure 9). Each animal was removed after 
10 min, dried and placed back in the standard condition cage. Twenty-four hours after the 
first exposure, animals were replaced in the water filled apparatus for 10 min and the 
session was recorded using a video camera placed above the bucket for subsequent 
analysis of behavioural response of fluoxetine treated and control rats. Swimming 
behaviour was defined as horizontal movements throughout the swim chamber. 
Immobility was considered as passive floating with only slight movements of tail or one 
hind limb. Climbing behaviour consisted of upward directed movements of the forepaws 
along the sides of the swim chamber.   
 
Figure 9. Scheme of the forced swim test. Animals are placed in the apparatus depicted, which is filled up 
with water (30 cm). During the FST rats exhibit three well recognized forms of behavior: immobility, 
swimming and climbing. Each session lasts 10 min. and is recorded using a video camera. Taken from 




To control for the spontaneous locomotor activity in both fluoxetine treated and 
control animals, we performed a mobility test at the end of antidepressant treatment using 
“Opto M3-2 cage system” with horizontal and vertical laser beam sensors. Spontaneous 
movement measurements for each animal were monitored at the end of chronic 
antidepressant treatment, from 00:00 to 06:00 am, by quantification of laser beam breaks 





Chronic fluoxetine administration restores OD plasticity in the adult visual cortex 
 
We initially investigated the effects of one week of monocular deprivation (MD) 
on the ocular dominance (OD) plasticity of adult animals chronically treated with 
fluoxetine, by recording visual evoked potentials (VEPs) in the binocular region of the 
primary visual cortex contralateral to the deprived eye. VEPs represent the integrated 
response of a population of neurons to patterned visual stimuli and are routinely used to 
evaluate visual acuity (VA) and binocularity alterations (Huang et al., 1999; Porciatti et 
al., 1999; He et al., 2006). We assessed OD (binocularity) calculating the contralateral to 
ipsilateral (C/I) VEP ratio, i.e. the ratio of VEP amplitudes recorded by stimulating the 
eye contralateral and ipsilateral, respectively, to the visual cortex where recording is 
performed. The C/I VEP ratio is around 2.5 in adult animals, reflecting the predominance 
of crossed fibres in the rat retinal projections. MD in control adult animals did not change 
binocularity in the visual cortex contralateral to the deprived eye (C/I VEP ratio 2.73 ± 
0.2,  n = 5) (Figure 10). In contrast, fluoxetine treated adult rats showed a marked OD 
shift in favor of the non deprived eye after MD (C/I VEP ratio 1.0 ± 0.08  t-test P < 
0.001, n = 5), thus displaying a plastic modification normally restricted to early stages of 




Figure 10. Reactivation of visual cortical plasticity in adulthood after chronic treatment with fluoxetine.  
MD in fluoxetine treated adult rats induced an OD shift of visual cortical neurons in favour of the non 
deprived eye (C/I VEP ratio 1.0 ± 0.08  t-test P < 0.001, n = 5) but not in control rats (C/I VEP ratio 2.73 ± 
0.2  n = 5). Error bars represent S.E.M.  indicates statistical significance. 
 
 
Chronic fluoxetine administration promotes the recovery of normal visual functions 
in adult amblyopic rats 
 
To further assess the effects induced by chronic treatment with fluoxetine on 
visual cortical plasticity we next evaluated the recovery of visual functions in adult rats 
that were rendered amblyopic by long-term MD and then reverse-sutured (RS) during the 
last two weeks of antidepressant treatment. We measured VA by recording VEPs from 
the VC contralateral to the long-term deprived eye. In control animals, VA of the 
formerly deprived eye did not show any sign of recovery (0.62 ± 0.06 c deg–1) compared 
to the fellow eye (1.06 ± 0.01 c deg–1) (Figure 11A). In contrast, fluoxetine treated adult 
rats showed complete rescue of VA (0.97 ± 0.04 c deg–1) in the formerly deprived eye.  
Behavioral measure of VA (using the visual water task), performed in the same animals 
before recording of VEPs, confirmed the electrophysiological data: complete recovery of 
VA (0.88 ± 0.02 c deg–1) was evident in fluoxetine treated long-term deprived rats but not 
in control animals (Fig. 11B).  
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Figure 11. Visual acuity recovery in adult amblyopic rats chronically treated with fluoxetine. VA of the 
formerly deprived eye assessed both electrophysiologically (A) and behaviourally (B) was lower than that 
of the fellow eye in control animals (paired t-test P < 0.001 for A and P < 0.001 for B, n = 5) but not in 
fluoxetine treated adult rats (paired t-test P = 0.703 for A and P = 0.354 for B, n = 5). Error bars represent 
S.E.M.  indicates statistical significance. 
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In the same animals in which VA was assessed, we also evaluated OD measuring 
the C/I VEP ratio. In control animals, there was no rescue of binocularity in the visual 
cortex contralateral to the formerly deprived eye (C/I VEP ratio 1.11 ± 0.20, n = 5) 
(Figure 12), whereas fluoxetine treated adult rats showed full recovery of binocularity 
with a C/I ratio of 2.25 ± 0.17. 
 
 
Figure 12. OD (binocularity) recovery in adult amblyopic rats after chronic treatment with fluoxetine. The 
C/I VEP ratio was significantly higher (t-test P < 0.002, n = 5) in the visual cortex of fluoxetine treated 
adult rats (C/I VEP ratio 2.25 ± 0.17) than in controls (C/I VEP ratio 1.11 ± 0.20, n = 5), and in the range of 
adult animals with normal vision. Error bars represent S.E.M.  indicates statistical significance. 
 
 
Chronic treatment with fluoxetine causes a reduction of intracortical inhibition 
 
Because there is evidence that the maturation of intracortical inhibitory circuitries 
causes the end of plasticity in the visual system (Fagiolini & Hensch, 2000; reviewed by 
Hensch 2005), we used in vivo brain microdialysis to investigate whether the fluoxetine 
induced visual cortical plasticity was accompanied by a decreased GABAergic 
transmission. Quantification of extracellular basal levels of γ-aminobutyric acid (GABA) 
revealed a significant reduction of intracortical inhibition in the visual cortex of 
fluoxetine treated adult rats (Figure 13A) compared to controls (two-way ANOVA 
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repeated measures P = 0.02 post hoc Holm-Sidak test P < 0.02, n = 5). No difference in 
extracellular glutamate (GLU) levels was detected between fluoxetine treated and control 
animals (two-way ANOVA repeated measures P = 0.494, n = 5) (Figure 13B). 
 
 
Figure 13. Reduced intracortical inhibition in the adult rat visual cortex after chronic antidepressant 
treatment. (A) In vivo brain microdialysis revealed that basal extracellular levels of GABA were 
significantly lower in fluoxetine treated animals than in control rats (two-way ANOVA repeated measures 
P = 0.02 post hoc Holm-Sidak test P < 0.02 where indicated, n = 5). (B) Extracellular basal GLU levels 
were not different between fluoxetine treated and control animals (two-way ANOVA repeated measures   P 




Chronic treatment with fluoxetine reactivates long-term potentiation of neural 
transmission in the adult visual cortex 
 
To further assess the reduction of intracortical inhibition, we then examined long-
term potentiation of layer II-III field potentials after theta-burst stimulation from the 
white matter (WM-LTP), a form of synaptic plasticity that is absent in the adult because 
of the maturation of intracortical inhibitory circuitries (Kirkwood et al, 1994). WM-LTP 
was fully restored in fluoxetine treated adult rats (Figure 14). No WM-LTP was present 




Figure 14. Long-term potentiation (LTP) of neural transmission in the adult visual cortex. LTP after theta-
burst stimulation (TBS) from the white matter (WM-LTP), measured 20-30 min after TBS, was 
significantly higher in the visual cortex of fluoxetine treated animals than in controls (two-ways ANOVA 
repeated measures P < 0.005 post hoc Student-Newman-Keuls test P < 0.01). Scale bars are 50% of 






Modulation of GAD65/67 expression induced by chronic fluoxetine administration 
 
To investigate the involvement of the GABA synthesizing enzymes GAD65/67 in 
the reduction of GABAergic inhibition, induced by chronic fluoxetine administration, we 
evaluated GAD65/67 protein expression in the visual cortex of adult animals using 
western blot following antidepressant treatment. Interestingly, the expression of 
GAD65/67 was increased in the adult rat visual cortex after chronic antidepressant 
treatment (t-test  P < 0.03, n = 5) (Figure 15). 
 
 
Figure 15. GAD 65/67 protein expression in the visual cortex after chronic fluoxetine administration. 
Western blot analysis evidence that GAD65/67 protein levels were increased (t-test P < 0.03, n = 6) in the 
visual cortex of adult animals after antidepressant treatment compared to control animals. Error bars 
represent S.E.M.  indicates statistical significance. 
 
 
We then thought of evaluate the expression of GAD65/67 in animals with a 
pharmacologically induced reduction of intracortical inhibition, a condition that mimics 
the effects induced by antidepressant treatment on the GABAergic inhibition. A different 
group of adult rats (P90) was cortically treated for one week with a non-epileptic dose of 
mercaptopropionic acid (MPA, 100 µM), by means of osmotic minipumps, to ultimately 
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assess GAD65/67 protein expression. Western blot analysis revealed an increased 
expression of the GABA synthesizing enzymes (t-test P < 0.03, n = 6) after MPA 




Figure 16. GAD 65/67 protein expression in the visual cortex after MPA administration. Western blot 
analysis show that GAD65/67 protein levels were higher (t-test P < 0.03, n = 6) in the visual cortex of adult 




Chronic fluoxetine treatment increases BDNF expression in the adult visual cortex 
 
Because chronic antidepressant administration increases the expression of the 
neurotrophin BDNF in limbic structures, most notably in the hippocampus, (Nibuya et al, 
1995; D’Sa & Duman, 2002) we measured BDNF protein levels, using the ELISA 
method, in the adult rat visual cortex after chronic fluoxetine administration. We found 
an increased expression of BDNF in the visual cortex of fluoxetine treated adult rats (t-
test P < 0.04, n = 6) (Figure 17A). BDNF protein expression was similarly enhanced in 





Figure 17. BDNF protein levels after antidepressant treatment. BDNF protein expression, quantified by 
means of ELISA, was significantly higher in the visual cortex (t-test P < 0.04, n = 6) (C) and hippocampus 
(t-test P < 0.01, n = 6) (D) of adult rats chronically treated with fluoxetine than in controls. Error bars 






Cortical diazepam administration prevents the effects induced by chronic treatment 
with fluoxetine in visual cortical plasticity 
 
To test whether the reduction of intracortical inhibition underlies the reopening of 
visual cortical plasticity in adulthood, we evaluated OD in fluoxetine treated adult rats 
that were cortically infused with the benzodiazepine agonist diazepam (2 mg ml–1) or 





Figure 18.  Schematic diagrams of the experimental procedure followed (top) and of the osmotic 
minipump implant and recording site of visual evoked potentials (VEPs) in the binocular visual cortex 
contralateral to the deprive eye (bottom). Cortical administration of the benzodiazepine agonist diazepam 




Cortical diazepam administration in adult rats chronically treated with fluoxetine 
totally prevented the OD shift induced by MD (Figure 19). Control animals 
intracortically infused with vehicle solution showed an OD shift in favor of the non 
deprived eye following MD (C/I VEP ratio 1.07 ± 0.04  t-test P = 0.01, n = 3). 
 
 
Figure 19.  Blockade of OD plasticity in fluoxetine treated rats intracortically infused with diazepam (Dz). 
The C/I VEP ratio in the visual cortex contralateral to the deprived eye after MD in fluoxetine treated adult 
animals that were cortically infused with the benzodiazepine agonist diazepam (Fluox + Dz) was not 
different from that of control (not deprived) animals (C/I VEP ratio 2.48 ± 0.29 t-test P = 0.483, n = 4) but 
it differed significantly from either that of adult rats chronically treated with fluoxetine (Fluox) (t-test P = 
0.001, n = 5) and that of animals cortically infused with vehicle solution (Fluox + Veh) (t-test P = 0.01, n = 
3). Error bars represent S.E.M.  indicates statistical significance.   
 
 
Antidepressant effects induced by chronic treatment with fluoxetine 
 
Given that fluoxetine is a prescribed medication for treatment of depression, we 
also evaluated the antidepressant effects induced by chronic administration of fluoxetine. 
We used a modified rat forced swim test, a widely recognized model for depressive 
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behavior in rodents (Cryan and Lucki, 2000). Fluoxetine treated adult rats showed 
increased swimming (t-test P = 0.013, n = 5) (Figure 20A) and decreased immobility (t-
test P = 0.025, n = 5) (Figure 20B) relative to behavioral responses of control animals, 
reflecting an antidepressant-like behavioral effect. Climbing behavior did not differ 












Figure 20.  Antidepressant effects induced by chronic fluoxetine administration. A modified version of the 
rat forced swim test (FST) revealed an antidepressant-like behavioural effect in fluoxetine treated adult rats, 
as evidenced by increased swimming (A) (t-test P = 0.013, n = 5) and decreased immobility (B) (t-test P = 
0.025, n = 5) compared to control animals. (C) Climbing behaviour did was not different between 
fluoxetine treated and control rats . 
 
 
To exclude that behavioural antidepressant effects produced by fluoxetine were 
due to an increased locomotor activity we performed a mobility test at the end of chronic 
antidepressant treatment, in both fluoxetine treated and control animals, using the “Opto 
M3-2 cage system”. Spontaneous locomotor activity of fluoxetine treated adult rats did 
not differ from that of control animals (t-test P = 0.865, n = 5) after chronic treatment 










Figure 21.  Spontaneus locomotor activity after chronic fluoxetine administration. Movement 
measurements in both experimental and control animals, assessed by quantification of laser beam breaks 
using the “Opto M3-2 cage system”, showed that spontaneous locomotor activity did not differ between the 
















Chronic fluoxetine administration restores OD plasticity in the adult visual cortex 
through a reduction of intracortical inhibition 
 
Visual cortical plasticity is known to be restricted to a critical period during early 
stages of brain development (for review see Berardi et al., 2000). The decline of plasticity 
in the adult has been attributed to different factors, for instance, to a shift in the 
composition of NMDA receptor subunits (Erisir & Harris, 2003), the activity of the CRE-
CREB system (Pham et al., 1999), and the condensation of extracellular matrix molecules 
in perineuronal nets mainly around inhibitory interneurons (Pizzorusso et al., 2002). In 
addition, it has been observed that the maturation of intracortical inhibitory circuitries is a 
critical molecular event which sets the threshold for both the start and the end of the 
critical period for visual cortical plasticity (Fagiolini & Hensch, 2000; reviewed in 
Hensch, 2005). The intracortical GABAergic inhibition is known to maturate slowly 
compared to excitation and it has been suggested that such a developmental mismatch 
between inhibition and excitation provides a temporal window for the critical period, 
when the organization of neuronal circuitries can be strongly influenced by sensory 
experience. Consistent with this notion, electrophysiological recordings of VEPs in the 
visual cortex of BDNF overexpressing mice that show an accelerated maturation of 
intracortical inhibition, evidence an accelerated closure of the critical period for OD 
plasticity and a precocious functional development of the visual cortex (Huang et al., 
1999).  
Here we demonstrate that chronic fluoxetine administration reopens visual 
cortical plasticity in the adulthood, as evidenced by the OD shift in response to MD in 
adult animals following antidepressant treatment (Figure 10). This effect was 
accompanied by a marked reduction of intracortical inhibition as evidenced in vivo by the 
diminishment of extracellular levels of GABA assessed through brain microdialysis. The 
reduction of the GABA mediated transmission after chronic antidepressant treatment was 
also evaluated electrophysiologically by assessing long-term potentiation of neural 
transmission in layers II-III after theta burst stimulation from the white matter (WM-
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LTP). This is a form of synaptic plasticity that is absent in the adult because of the 
maturation of intracortical inhibitory circuitries (Kirkwood et al, 1994) but it can be 
restored if the GABA mediated inhibition is reduced (Artola & Singer, 1987). Consistent 
with this notion and the in vivo analysis, we observed an increased WM-LTP in adult rats 
chronically treated with fluoxetine. We provide evidence that the reduction of 
intracortical inhibition induced by chronic treatment with fluoxetine is a critical event to 
restore plasticity in the adult visual cortex, since an enhancement of the inhibitory tone 
through cortical infusion of the benzodiazepine agonist diazepam in fluoxetine treated 
rats, prevented the OD shift of cortical neurons following MD (Figure 19). The effect 
induced by the benzodiazepine diazepam on OD plasticity was drug-specific since 
cortical administration of vehicle solution did not prevent the shift of OD after MD.  
Our results are in agreement with different studies which point toward the 
reduction of the GABAergic transmission as a key molecular event for restoring plasticity 
in the adult visual cortex. For instance, a pharmacologically induced reduction of 
intracortical inhibition through cortical administration of a non-epileptic dose of 
mercaptopropionic acid (MPA; 100 μM) in adult rats, effectively reactivates OD 
plasticity as evidenced by single cell recordings in the binocular area of the primary 
visual cortex after one week of MD (Harauzov, 2001). In addition, a reduction in the 
expression of GABAA receptors which is expected to mediate a diminishment of the 
inhibitory GABAergic transmission, has been shown to occur in the visual cortex of adult 
animals transiently deprived of visual input by dark exposure, a treatment that restores 
OD plasticity in the adulthood (He et al., 2006). 
 The reduction of intracortical inhibition as a mechanism that reinstates plasticity 
in the adult visual cortex may seem to be in contrast with the fact that lowering the 
inhibitory tone during development, as in the case of GAD65 knockout mice, decreases 
visual cortical plasticity (see Katz, 1999). GAD65 transgenic mice, indeed, do not show 
susceptibility to MD at any age unless eye-lid suture is coupled to cortical administration 
of the benzodiazepine agonist diazepam (Hensch et al., 1998). Such discrepancy, 
however, may be explained by the fact that the maturation of intracortical inhibitory 
circuitries sets the threshold for both the start and the end of the critical period for visual 
cortical plasticity (see Berardi et al., 2003). Indeed, there is an initial inhibitory threshold 
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to be surpassed before the critical period can start, which accounts for the delayed onset 
of the critical period in GAD65 knockout mice with reduced levels of inhibition. It also 
would explain the early onset of the critical period induced by early diazepam 
administration. Additionally, there is a second inhibitory threshold during late 
development that causes the critical period closure, which accounts for the precocious 
visual cortical development in BDNF overexpressing mice that show an accelerated 
maturation of intracortical inhibition.  
 
Chronic treatment with fluoxetine promotes the recovery of vision in adult 
amblyopic rats 
 
The recovery of vision in one eye due to a transient improper use of that eye is 
another classical model of plasticity in the visual system. It is known to be restricted to 
the critical period during postnatal development and is absent in the adult because of a 
decline of plasticity that has been largely attributed to the maturation of intracortical 
inhibition (Fagiolini & Hensch, 2000). Here, we evaluated the recovery of normal visual 
functions in the adulthood after long-term MD (amblyopia). We demonstrate that chronic 
antidepressant treatment in parallel to reverse suture, i.e., eye-lid suture of the fellow eye 
while opening of the formerly deprived eye, during the last 2 weeks of fluoxetine 
administration, promotes the recovery of vision in adult amblyopic rats, as tested 
electrophysiologically through VEPs recordings in the visual cortex and behaviourally 
using the visual water box task. In particular, we observe a complete recovery of visual 
acuity (Figure 11A, B) and binocularity (Figure 12) in the visual cortex contralateral to 
the formerly deprived eye after chronic antidepressant treatment.  
Our findings are consistent with previous studies in which we have shown that a 
reduction of intracortical inhibition underlies the recovery of visual functions in long-
term deprived animals exposed to environmental enrichment, a condition characterized 
by an increased exploratory behaviour and sensory-motor stimulation (Sale et al., 2007). 
Particularly, we demonstrated that adult amblyopic rats housed under environmental 
enrichment for 2 weeks showed full recovery of visual acuity and binocularity, assessed 
by recording VEPs in the primary visual cortex contralateral to the long term deprived 
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eye. Behavioural visual acuity was demonstrated as well. Importantly, an enhancement of 
the inhibitory tone through cortical administration of the benzodiazepine diazepam during 
the environmental enrichment period prevented the recovery of vision in adult amblyopic 
animals. More recently, the recovery of normal visual functions in adult amblyopic rats 
has been shown to occur if a brief period of complete visual deprivation precedes the 
reverse suture procedure in long-term deprived animals (He et al., 2007). Specifically, 
recordings of VEPs in the visual cortex showed that a 10 days period of dark exposure, 
which preceded the reverse suture, promotes the recovery of both spatial visual acuity 
and binocularity. As previously mentioned, the reinstatement of OD plasticity in the 
adulthood induced by dark exposure involves a reduction of intracortical inhibition (He et 
al., 2006).  
 
Shift of the intracortical inhibitory-excitatory balance mediated by an increased 
serotonergic transmission following chronic antidepressant treatment 
 
Neuromodulatory transmitter systems such as acetylcholine, adrenaline, 
noradrenaline and serotonin diffusely project to the neocortex and the inhibitory or 
excitatory action of each transmitter on cortical neurons depend on the composition of the 
postsynaptic receptor subtypes. The overall functions of these transmitters are believed to 
serve as the chemical basis or arousal, attention and motivation. In particular, cortical 
innervation of serotonin originates in the raphe nucleus in the brainstem (Azmitia & 
Segal, 1978). 5-HT containing terminals are present in all cortical areas and all cortical 
layers and make synaptic contacts with pyramidal neurons (Takeuchi & Sano, 1984; 
Papadopoulus et al., 1987) and with GABAergic interneurons as well (DeFelipe et al., 
1991). An important role for serotonergic transmission in modulating visual cortical 
plasticity has also been highlighted (reviewed in Gu, 2002).  
Fluoxetine, a widely prescribed medication for treatment of depression, 
selectively inhibits the presynaptic reuptake of 5-HT which enhances the postsynaptic 
serotonergic transmission (see Figure 2). Our findings that chronic antidepressant 
treatment restores plasticity in the adulthood, suggest that the enhanced serotonergic 
transmission induced by fluoxetine administration promotes functional and/or structural 
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mechanisms that shift the intracortical inhibitory-excitatory balance in the visual cortex. 
A reduction of extracellular levels of GABA (Figure 13A) relative to those of GLU 
(Figure 13B) may decrease the threshold for visual cortical neurons to be driven by 
electrical activity, thus allowing the visual cortex to respond rapidly to manipulations of 
the visual input, like MD and reverse suture in the adulthood.    
These observations in the adulthood are in agreement with the role of 5-HT in OD 
plasticity of the cat visual cortex observed during development. For instance, cortical 
administration of two different serotonergic receptor antagonists: ketanserin and 
methysergide, caused a reduction of OD plasticity in the kitten visual cortex in response 
to MD (Bradley et al., 1986). Likewise, it has been shown that chronic infusion of the 
serotonin neurotoxin (5,7-DHT) into the kitten visual cortex, in parallel to eye-lid suture 
of one eye, prevented the OD shift of visual cortical neurons following MD. The majority 
of neurons in the 5,7-DHT treated hemisphere, indeed, remained binocular while most 
neurons in control animals displayed a normal shift of OD toward the non deprived eye 
(Gu & Singer, 1995). Moreover, intracortical infusion of mesulergine, a specific 5-HT2C 
receptor antagonist, reduced the OD shift of cortical neurons in the visual cortex of 
kittens monocularly deprived (Wang et al., 1997). Taken together, these observations 
suggest that serotonin contributes to OD plasticity in young animals, and that 
serotonergic signaling through the 5-HT2C receptor subtype plays a critical role in 
activity-dependent synaptic modifications of the cat visual cortex during development.  
A mechanism associated with NMDA receptor synaptic modifications has long 
been considered to explain the permissive action of 5-HT in OD plasticity. It has been 
demonstrated in vitro that 5-HT enhances the depolarizing responses to excitatory amino 
acids in the neocortex of cats (Nedergaard et al., 1987) and rats (Reynolds et al., 1988) 
and promotes synaptic plasticity in the kitten visual cortex as well (Kojic et al., 1997). 
These effects could be achieved by a reduction of membrane K+ conductances in 
pyramidal neurons (Andrade & Chaput, 1991; Fagni et al., 1992) which may lead to a 
slow membrane depolarization which in turn would enhance the influx of Ca2+ ions into 
the cell through NMDA receptors. Another possibility is that synergistic interactions at 
intracellular second messengers level may enhance the intracellular signals induced by 
the excitatory inputs. Because activation of the 5-HT2C receptor stimulates phospholipids 
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turnover (Hoyer & Martin, 1997), serotonin could contribute to the enhancement of 
intracellular responses to sensorial inputs via an increase of inositol triphosphate (IP3) 
and diacylglycerol (DAG), both arising from the cleavage of the membrane lipid 
phosphatidylinositol biphosphate (PIP2). An increase of IP3 may enhance Ca2+ release 
from intracellular compartments and induce the activation of Ca2+-dependent protein 
kinases, whose activity is required for visual cortical plasticity during development as 
previously demonstrated by Di Cristo et al. (2001). Here, we show that a reduction of 
intracortical inhibition is an additional mechanism through which an enhanced 
serotonergic transmission, induced by chronic fluoxetine administration, may facilitate 
visual cortical plasticity. Our findings suggest the possibility that the composition of 
serotonergic receptors on GABAergic interneurons may mediate the reduction of GABA 
release we observed in the adult visual cortex after antidepressant treatment. The 
reduction of intracortical inhibition relative to excitation induced by chronic 
antidepressant treatment would increase the probability that visual inputs drive cortical 
neurons above the threshold that must be reached to promote functional modifications of 
neuronal networks in the adult visual cortex. 
 
GAD65/67 protein expression following chronic treatment with fluoxetine 
 
One presynaptic mechanism by which an increased serotonergic activity may 
cause a reduction of the GABA mediated inhibition is a diminishment of the expression 
of the GAD isoforms GAD65/67. To test this possibility, we assessed GAD65/67 protein 
expression in the visual cortex of fluoxetine treated adult rats. Interestingly, the 
expression of GAD65/67 was increased in the adult rat visual cortex after chronic 
antidepressant administration compared to control animals (Figure 15). We next reasoned 
that if the reduction of the extracellular levels of GABA induced by chronic 
antidepressant treatment causes an increase of GAD65/67 expression as a homeostatic 
mechanism for reestablishing the physiological inhibitory tone, then a pharmacologically 
induced reduction of intracortical inhibition in the visual cortex should increase 
GAD65/67 expression as well. We thus analyzed the expression of GAD65/67 in the 
visual cortex of animals cortically infused with a non-epileptic dose of 
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mercaptopropionic acid (MPA; 100 μM), treatment that blocks the enzymatic activity of 
GAD and restores plasticity in the adult visual cortex of the rat (Harauzov et al., 2001). 
Western blot analysis revealed an increased GAD65/67 protein expression in the visual 
cortex of MPA treated animals (Figure 16), to an extent similar to that observed in 
fluoxetine treated rats. Taken together, our findings suggest that chronic antidepressant 
treatment decrease extracellular basal levels of GABA in the adult visual cortex through a 
mechanism independent of GAD protein expression. To which extent it does involve a 
reduction of the enzymatic activity of the protein GAD or a decrease of the 
neurotransmitter release from synaptic vesicles in presynaptic terminals of GABAergic 
interneurons will require additional investigation.    
The modulation of GAD65/67 expression observed in adult animals chronically 
treated with fluoxetine is consistent with previous studies in which we have observed an 
increased expression of GAD65/67 in adult animals housed under enriched 
environmental conditions. As previously mentioned, environmental enrichment causes a 
reduction of intracortical inhibition, which reinstates plasticity in the adult visual cortex 
(Sale et al., 2007). In particular, GAD65/67 expression in the visual cortex of long-term 
MD animals housed under enriched environmental conditions for two weeks was shown 
to be increased as tested by western blot (unpublished data). Moreover, analysis of 
GAD65-immunoreactivity in presynaptic boutons of GABAergic interneurons 
surrounding the soma and proximal dendrites of target pyramidal neurons (puncta-ring 
structures) in the visual cortex of long-term MD animals following environmental 
enrichment, confirmed the biochemical data: an increased density of puncta-rings 
structures was observed in the visual cortex of adult rats with reduced levels of 
intracortical inhibition after environmental enrichment conditions (unpublished data).     
 
BDNF protein expression in adult visual cortex following antidepressant treatment
 
Chronic antidepressant administration is known to increase the expression of 
BDNF in limbic structures, most notably in the hippocampus (Nibuya et al, 1995), a 
molecular event that has been correlated with the therapeutic effects induced by ADs (for 
review see D’Sa & Duman, 2002; Castren et al., 2004). Consistent with these findings, 
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we observed an increased expression of BDNF in the visual cortex of fluoxetine treated 
adult rats compared to control animals (Figure 17A). BDNF protein expression was 
enhanced in the hippocampus as well (Figure 17B). It has been suggested that 
antidepressants may up-regulate the expression of genes essential for maintaining 
synaptic function and cell survival through an increase of CREB phosphorylation, a 
transcription factor that enhances BDNF expression (Poo, 2001).  
Functional brain imaging studies have shown a reduction in glucose metabolism 
and blood flow in the limbic and prefrontal cortex of depressed patients (Drevets, 2000), 
findings that suggest that neuronal activity may be decreased in the pathology of 
depression. Indeed, a reduced gray matter volume in the prefrontal cortex (Bremner et al., 
2002; Botteron et al., 2002) and hippocampus (MacQueen et al., 2003; Sheline, 2003) of 
depressed patients has been observed, and such morphological alterations seem to be 
reversed by ADs (Drevets, 2000). These observations together with the fact that BDNF 
mediates the behavioral response to ADs, raises the possibility that BDNF expression 
may be required to promote neuronal plasticity in the adult nervous system. Early studies 
of the effects of neurotrophins in visual cortical plasticity, however, revealed no effects 
induced by cortical administration of BDNF on OD plasticity after MD in the adulthood 
(Galuske et al., 2000; Hata et al, 2000). In particular, BDNF infusion into the visual 
cortex of adult cats in parallel to MD showed no variations on OD distribution of visual 
cortical neurons, as tested using single cell recordings. These findings make it unlikely 
the possibility that BDNF expression may account completely for the restoration of 
plasticity observed in the adult visual cortex after chronic antidepressant treatment. 
Consistent with this notion, BDNF overexpressing mice do not show any susceptibility to 
MD in the adulthood (Huang et al., 1999).  
On the other hand, BDNF heterozygous knock-out mice (BDNF+/-) show no 
impairments in the closure of the critical period for MD (Bartoletti et al., 2002). Because 
the overexpression of BDNF causes an accelerated closure of the critical period for OD 
plasticity, it was tested whether the critical period for visual cortical plasticity was 
prolonged in transgenic mice with reduced BDNF levels (BDNF+/-). Single cell 
recording analysis in the visual cortex of adult transgenic mice showed a normal closure 
of the critical period for OD plasticity (Bartoletti et al., 2002). In addition, long-term 
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potentiation of layer II-III field potentials after TBS from the white matter (WM-LTP), in 
the visual cortex of BDNF+/- or wild-type littermates, was normally absent in the 
adulthood. Only an impairment in long-term potentiation of neural transmission of layer 
II-III field potentials after TBS from layer IV was observed in BDNF+/- mice. These 
findings suggest a role for BDNF in mechanisms of synaptic plasticity as reported for 
hippocampal LTP (Kang & Shuman, 1995; Ying et al., 2002) but not in restoring 
neuronal plasticity in the adult visual cortex. Interestingly, the increase in protein BDNF 
levels we observed after chronic antidepressant treatment seems to be slighter than the 
extent to which the GABA mediated inhibition is reduced. Whether or not such 
experimental observations hold true will require additional investigation. 
 
BDNF and GAD65/67 interaction in the adult rat visual cortex 
 
The increased expression of BDNF in the adult rat visual cortex observed after 
chronic antidepressant treatment is a molecular mechanism that correlates with an 
increased GAD65/67 expression. During development, an increased BDNF expression 
induces an accelerated closure of the critical period for OD plasticity, an effect that has 
been attributed to a precocious maturation of intracortical inhibition in the visual cortex 
(Huang et al., 1999). Indeed, an increased GAD65-immunoreactivity in presynaptic 
boutons of GABAergic interneurons surrounding the soma and proximal dendrites of 
target pyramidal neurons (puncta-ring structures), has been evidenced in the visual cortex 
of BDNF overexpressing mice. In agreement with these observations, adult rats 
chronically treated with fluoxetine not only show increased levels of BDNF (Figure 17A) 
but also an increased expression of GAD65/67 (Figure 15) in the visual cortex. Taken 
together, our results suggest a neurotrophic effect of BDNF on GABAergic interneurons 
which accounts for the increased expression of the GABA synthesizing enzymes, as 
observed for BDNF overexpressing mice during development. In agreement with this 
notion, analysis of GAD65-immunoreactivity in presynaptic boutons of GABAergic 
interneurons surrounding target pyramidal neurons (puncta-ring structures) in the visual 
cortex of TrkB dominant negative mice demonstrate that the up-regulation of GAD65/67 
expression induced by chronic fluoxetine administration (0,08 mg ml–1) requires BDNF 
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signaling. The density of puncta rings in the visual cortex of wildtype mice, indeed, is 
increased after chronic antidepressant treatment and such an effect does not occur in the 
visual cortex of TrkB dominant negative mice with a reduced BDNF-TrkB signaling 
(O’Leary O.F. & Castren E., personal communication). We propose that the reduction of 
extracellular GABA levels induced by chronic antidepressant treatment (Figure 13A) 
occurs through a mechanism that is independent of the GAD65/67 expression, and allows 
a functional modification of neuronal circuitries which underlies the sensitivity to MD in 
the adult and amblyopia recovery. In addition, we suggest that a reduction of intracortical 
inhibition in the adulthood, which shift the intracortical inhibitory-excitatory balance, 
may cause an increase in the expression of BDNF which is activity-dependent. 
Furthermore, the expression of BDNF might eventually enhance the inhibitory 
transmission in parallel to the increasing BDNF levels thus representing a negative 
feedback loop which may regulate the neurotrophin expression.   
 
Long-term potentiation of neural transmission in the adult rat visual cortex 
following antidepressant treatment 
 
As previously mentioned, we observed the occurrence of WM-LTP in the visual 
cortex of fluoxetine treated rats (Figure 14), a phenomenon that is usually absent in the 
adult but can be restored if the GABA mediated inhibition is reduced (Artola & Singer, 
1987; Kirkwood & Bear, 1994), finding that is in agreement with the reduction of 
intracortical inhibition observed in vivo using brain microdialysis after chronic fluoxetine 
administration (Figure 13A). The increase of synaptic plasticity (WM-LTP) in the adult 
rat visual cortex following antidepressant treatment is consistent with recent observations 
which show that chronic administration of ADs in healthy human subjects increases the 
amplitude of the P1 and N1 components of VEPs in response to repeated presentation of 
visual stimuli, event that has been suggested to be a form of long-term synaptic plasticity 
(Normann et al., 2007). This form of plasticity has been previously described in the 
visual cortex of the awake mice. In particular, it has been observed that repeated 
presentation of grating stimuli of a single orientation promotes a persistent enhancement 
of cortical responses evoked by subsequent visual stimuli (Frenkel et al., 2006). This 
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response potentiation is specific to the orientation of the stimulus, develops gradually 
over the course of time and occurs in both juvenile and adult mice. Consistent with these 
findings, Normann et al. (2007) demonstrated that 10 min presentation of a checkerboard 
reversal stimuli (2 rps), causes an increase in the amplitude of early components (P1, N1) 
of VEPs in response to subsequent presentation of the stimulus in healthy human 
subjects. Furthermore, the authors demonstrated that prolonged visual stimulation causes 
a plastic modification of cortical responses in healthy individuals chronically treated with 
the SSRI sertraline compared to that observed in non-treated healthy human subjects 
(Normann et al., 2007).      
 Taken together these findings suggest that the increase of synaptic plasticity 
(WM-LTP) which is described here in the rodent visual cortex, may also take place in the 
human brain after chronic treatment with fluoxetine. Moreover, our results open the 
possibility that chronic administration of SSRIs may promote similar effects also in other 
brain areas, such as those involved in mood regulation in depressed patients, which 
highlights new mechanisms for the therapeutic effects induced by ADs and the 
pathophysiology of mood disorders. 
 
Antidepresssant-like behavioural response induced by chronic fluoxetine 
administration 
 
Given that fluoxetine is prescribed for treatment of depression, we also evaluated 
the antidepressant effects induced by chronic administration of the drug. We observed an 
antidepressant-like behavioral response in fluoxetine treated adult rats compared to 
control animals, as evidenced by increased swimming (Figure 20A) and decreased 
immobility (Figure 20B) in the forced swim test (FST). Climbing behavior did not differ 
between fluoxetine treated and control animals (Figure 20C). The immobile behavior is 
thought to reflect either a failure to persist in escape-directed behavior after persistent 
stress or the development of passive behavior that disengages the animal from active 
forms of coping with stressful stimuli. Our results are in agreement with previous studies 
addressing the behavioral response induced by SSRIs in rodents. It has been observed 
that different behavioral components in the FST distinguish neurochemically distinct 
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antidepressant drugs (Lucki, 1997). For instance, swimming behavior is sensitive to 
SSRIs and 5-HT agonists whereas climbing behavior shows sensitivity to tricyclic 
antidepressants or drugs with selective effects on catecholamine transmission (Detke et 
al., 1995). The increased swimming behavior produced by fluoxetine, indeed, is 
prevented by treatment with inhibitors of the protein tryptophan hydroxylase: one of the 
two enzymes required for the synthesis of serotonin, but not the increased climbing 
behavior produced by the norepinephrine reuptake inhibitor desimipramine (Page et al., 
1999). To control that the behavioural responses produced by fluoxetine were not due to 
an increased locomotor activity induced by a diminishment of inhibition, we performed a 
mobility test at the end of chronic antidepressant treatment. Spontaneous locomotor 
activity of fluoxetine treated adult rats did not differ from that of control animals after 
chronic treatment (Figure 21). These findings indicate that the effects induced by chronic 
fluoxetine administration in adult visual cortical plasticity occur in parallel to the 
antidepressant-like behavioural responses normally described for ADs.    
 
Potential clinical application for chronic antidepressant treatment in amblyopia and 
other neurological disorders
 
Our finding that fluoxetine, a widely prescribed AD in humans, restores plasticity 
in the adult visual system and the recovery of normal visual functions in adult amblyopic 
rats, suggests a possible clinical application for SSRIs in amblyopia and neurological 
disorders where synaptic plasticity is compromised due to an excessive intracortical 
inhibition. Accumulating evidence indicates that plasticity in the rat visual cortex can be 
modulated in the adulthood. For instance, the enzymatic degradation of extracellular 
matrix (Pizzorusso et al., 2002; 2006), environmental enrichment (Sale et al., 2007), and 
complete visual deprivation by dark exposure (He et al., 2006), actually promote 
plasticity in the adulthood and allow the recovery of normal visual functions in adult 
amblyopic animals. The fact that fluoxetine administration, a widely used medication in 
humans, is a non-invasive treatment that reinstates visual cortical plasticity in the 
adulthood, highlight that chronic SSRIs administration may be used as a complementary 
treatment to current therapies for human amblyopia.  
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The reduction of intracortical inhibition induced by chronic fluoxetine 
administration suggests a clinical value for SSRIs that is relevant for treatment of other 
neurological disorders as well. For instance, a pharmacotherapy based on a reduction of 
hippocampal inhibition for cognitive impairments in a mouse model of down syndrome 
(DS) has been recently suggested (Fernandez et al., 2007). In particular, transgenic 
Ts65Dn mice which have an extra copy of the mouse chromosome 16: a segment 
homologous to human chromosome 21 that contains much of the genetic material 
responsible for the DS phenotype, were used in this study. Ts65Dn transgenic mice show 
an excessive inhibition in the dentate gyrus of the hippocampus, a condition that has been 
proposed to compromise synaptic plasticity and mnemonic processing (Kleschevnikov et 
al., 2004). Chronic systemic treatment with non epileptic doses of two GABAA receptor 
antagonists: picrotoxin (PTX) and pentylenetetrazole (PTZ), in Ts65Dn mice, was shown 
to rescue cognition deficits as tested behaviorally in the object recognition test. 
Moreover, LTP deficits in the dentate gyrus of the hippocampus normally observed in 
Ts65Dn mice were rescued after chronic treatment with PTX and PTZ (Fernandez et al., 
2007). These findings suggest the possibility that over-inhibition contributes to cognition 
deficits associated with down syndrome and that chronic fluoxetine administration may 
be of clinical value for treatment of this neurological disorder.     
 Rett syndrome (RTT) is also a neurological disorder in which mutations of the 
MECP2 gene causes an excessive intracortical inhibition that compromises synaptic 
plasticity (Dani et al., 2005). Whole-cell-patch-clamp recordings in cortical slices of 
Mecp2-null mutant mice have evidenced that spontaneous activity of pyramidal neurons 
is reduced in this transgenic model of RTT. In particular, analysis of miniature excitatory 
postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents 
(mIPSCs), have shown that the balance between inhibition and excitation is shifted in 
favour of inhibition in the primary somatosensory cortex of Mecp2-null mice. All these 
findings, together with the fact that chronic fluoxetine administration restores plasticity 
by reducing intracortical inhibition, makes the antidepressant treatment a potential 
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